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Summary of Main Findings 
The report addresses treated drug misuse in Ireland. The findings are based on information gained 
from the National Drug Treatment Reporting System. All contacts receiving treatment from 
participating centres for their problem drug taking in 1996 are reported to the System. Treatment 
was provided by a range of statutory and voluntary agencies. This database is maintained by the 
Drugs Research Division of the Health Research Board. 
The main findings were: 
∗ The total number of contacts receiving treatment for drug misuse during 1996 was 4865, 
most of these were resident in the Eastern Health Board area 
∗ The number who entered treatment for drug misuse for the first time in 1996 was 2041 
persons 
∗ Almost three-quarters of clients were male 
∗ Most clients, 96%, were between 15 and 39 years old; almost two thirds were under 25 
years of age 
∗ Almost seven out of ten lived with their parental family and proportionately more women 
than men were living with a drug misusing partner 
∗ Almost a quarter of contacts treated for drug misuse lived in the inner city of Dublin 
∗ Fifty-eight percent had left school on or before the official school leaving age of 15 
∗ Eighty-three percent of contacts treated for drug misuse were unemployed 
∗ Two out of five had taken a drug, other than alcohol, before the age of 15 years 
∗ Heroin was the main drug of misuse in the Eastern Health Board area; cannabis and ecstasy 
featured more commonly in other health board areas 
∗ The percentage of those treated for heroin use has doubled in the period 1990 to 1996 
∗ In Dublin there is a trend towards more smoking and less injecting of the misusers’ main 
drug 
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Chapter 1 
Introduction 
This report provides information regarding treated drug misuse in the Republic of Ireland. Drug 
misuse which occurs outside the treatment context is not included and its extent is unknown. 
Centres where drug misuse is treated throughout the country return information to the Drugs 
Research Division of the Health Research Board, on all contacts treated by them on an ongoing 
basis. The present report is based on this data. 
The National Drug Treatment Reporting System grew from a Reporting System which addressed 
drug misuse in Dublin only [see O’Hare and O’Brien 1992 for historical background to the 
development of the system]. Annual reports on data from the Dublin area are available since 
1990. As a response to the growing concern relating to drug misuse and its societal and personal 
consequences the Reporting System was expanded to cover the entire country in 1995. The first 
national report published, referred to 1995 data [O’Higgins and Duff 1997]. The present report is 
the second national report. 
The primary objective or rationale for this report, is to provide policy makers and the treatment 
centres which return data to the Drugs Research Division with composite information on treated 
drug misuse, thus to contribute to an understanding of the epidemiology of such drug misuse in 
Ireland. Another objective is to provide information relevant to the healthcare and social 
implications of drug misuse and over time to examine trends in problematic drug use. 
In addition, the report provides valuable input to work carried out by the Drugs Research Division 
of the Health Research Board in a collaborative European context. Of particular note here is the 
Drugs Research Division’s participation in the Council of Europe Tompidou Group’ which 
examines from a multidisciplinary point of view the problems of drug misuse and exchanges 
information on measures to combat drug misuse at a city and a national level. The Drugs 
Research Division has also been designated as the ‘National Focal Point’ for drug related 
comparative European wide research and information gathering, carried out under the auspices of 
the European Union’s European Monitoring Centre for Drugs and Drug Addiction [EMCDDA] 
which is based in Lisbon. 
Coverage of Treated Drug Misuse 
This report is concerned with persons who received treatment during 1996 at any one of the 
centres participating in the reporting system. The Centres cover a range of services and facilities 
including both medical and non-medical care. Some of these centres are operated by statutory 
bodies and some are voluntary agencies. Although in 1996, a total of eighty six centres were 
identified as pertinent agencies to participate in the National Drug Treatment Reporting System, 
not all of them did so. Amongst the reasons for Centres not returning data were - clients may not 
have presented for treatment or Centres may not have been in a position to make returns, due for 
example, to lack of resources. 
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Table 1.1. Number of Treatment Centres Providing/Not Providing Returns in 1996 in 
Health Board Areas. 
 Returns No Returns Total - Centres 
Participating 
Eastern Health Board 25 13 38
Southern Health Board 2 6 8
North-Western Health Board 2 2 4
Midland Health Board 6 4 10
Western Health Board 1 3 4
Mid-Western Health Board 5 6 11
North-Eastern Health Board 0 2 2
South-Eastern Health Board 5 4 9
Total 46 40 86
The table above outlines the total number of centres in each Health Board Area, along with 
details of whether returns were made or not. It is important to bear in mind that no direct 
comparisons can be made here. The potential numbers which could have been returned by any 
one centre can vary from one return to several hundred. Accordingly the numerical significance 
to the National Drug Treatment Reporting System of a centre not returning information will vary. 
Nevertheless the table does provide some indication of the level of participation by treatment 
centres in the different health board areas in the Reporting System. Appendix D lists the centres 
which returned data for 1996 and briefly describes the services they provide. Centres which are in 
the System but which did not return information for 1996 are excluded from this list. 
There are two major gaps in the Reporting System as it exists at present. Firstly data from the 
prison services is not included and secondly drug misuse treated by General Practitioners is 
excluded. It is estimated that inclusion of these groups would increase the figures considerably 
and give a more accurate picture of treated drug misuse in Ireland. It is hoped to launch a 
Feasibility Study which should afford the possibility of including these sources within the 
Reporting System in 1999. In conclusion, it is felt that the centres which have returned data, 
represent reasonable coverage of treated drug misuse in Ireland. 
Data Collection 
The data included in this report is gathered on the basis of a form completed by each of the 
treatment centres for each of their clients (see Appendix E for a copy of the form). In obtaining 
the co-operation of treatment centres, the objectives and the value of assembling and reporting the 
data are discussed with the staff and assurances regarding the confidential nature of the data are 
given. No names appear on the questionnaires and no information from an individual 
participating centre is divulged to third parties. The data collected falls into two main categories 
as follows: 
(a) Total Treatment Contacts - refers to the reporting of all clients receiving treatment at 
any time during the calendar year of 1996 and is often referred to as ‘All Contacts’; 
(b) First Treatment Contacts - refers to a subset of clients who, during the year in 
question, entered treatment for the first time, never having had previous treatment 
anywhere for problem drug use. 
The Total Treatment Contacts, or All Contacts, referred to in this report signify cases, and not 
individuals. In contrast, the First Treatment Contacts or one-year Treated Incidence, refers to 
persons who received treatment for the first time ever during 1996 - this data refers to individuals. 
Over time first treatment data can point to trends and changing patterns of problematic drug use. 
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Definitions Used in the Report 
Drug Misuse: Drug misuse can be defined in a number of ways and can include the misuse of for 
example alcohol and tobacco. The working definition of drug misuse used in this Report is more 
narrow - the taking of a legal and/or illegal drug or drugs (excluding alcohol other than as a 
secondary drug of misuse and tobacco) which harms the physical, mental or social well-being of 
the individual, the group or society. 
Drug Treatment: any activity which is targeted directly at people who have problems with their 
drug use and which aims to ameliorate the psychological, and medical or social state of 
individuals who seek help for their drug problems. This activity will often take place at 
specialised facilities for drug users, but may also take place in general services offering 
medical/psychological help to people with drug problems. 
Various therapies are used in the treatment of clients at the centres. These range from medical 
treatments, such as detoxification, methadone programmes or drug-free programmes to non-
medical therapies which can include addiction counselling, group therapy and psychotherapy. 
Therapies are generally provided by professionally qualified personnel. Apart from specialised 
centres, drug treatment may be provided in hospitals, therapeutic communities, residential 
centres, out-patient clinics, community facilities, street agencies, prisons and by general 
practitioners. Under the definition of treatment used in this report, information given over the 
telephone, or information solely concerned with queries about social welfare entitlements or 
benefits are not included as treatment. 
Total Treatment: The operational definition is the number of cases, as distinct from persons, who 
received treatment as defined above from any of the drug treatment centres listed in Appendix D. 
First Treatment: The definition used here is that of persons who receive treatment for the first 
time ever and who had not been treated anywhere else for their problem drug use. 
Primary Drug: The primary drug is defined as the drug which, at the time of the current treatment 
contact, the client alleges is causing most problems and for which he or she has sought treatment. 
Frequency of Use: This term refers to how often a person has used their primary drug 
within the 30 days prior to contact with the centre. 
Sharing: The term refers to whether a person has shared injecting equipment. As noted in 
previous reports, ‘sharing’ is a difficult concept to define since its practice is understood 
differently by different people. Sharing injecting equipment with a partner is often not regarded 
as ‘sharing’. Therefore it will be difficult to assess accurately the level of sharing of equipment as 
treatment centres must take clients’ accounts of their practices. 
Parental Family: This term is used for people who are living with their family of origin, whether 
with parents and siblings or with their more extended family of grandparents, aunts and uncles. 
Opiates: The term ‘opiates’ when used in the text refers to opiates and opioids, both natural and 
synthetic. A classification of drugs can be found in Appendix F. 
Area of Residence: The area of residence of clients was classified according to the Street Index 
(Johnson et al 1987) used by personnel in the Eastern Health Board. 
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Contents of the Report 
This report provides a descriptive account of data gathered through the National Drug Treatment 
Reporting System on treated drug misuse for 1996. For the most part, the report deals with the 
‘Total Treatment’ or ‘All Contacts’ group. ‘First Treatment’ data are discussed only when 
considered to be particularly relevant. Since the latter comprised 43% of the total treatment 
group, in many cases overall conclusions emerging were identical. 
Chapter 2 provides an overview of the numbers involved in treated drug misuse on a national 
basis. Socio-demographic characteristics, living arrangements, aspects of drug misuse and risk 
behaviour are discussed. 
Chapter 3 examines regional variation in numbers involved in treated drug misuse in Ireland, 
characteristics of misusers and aspects of problem drug misuse. The unit of analysis here is the 
Health Board Area. 
Chapter 4 explores trends in treated drug misuse over a seven year period from 1990 to 1996 in 
the Greater Dublin Area. 
Chapter 5 - the final chapter, provides pen pictures of different categories of drug misusers. 
A summary is provided at the end of those chapters where results of data analyses are presented. 
A number of tables and figures are presented in text. Tables with letter and number designation 
refer to tables which can be found in the Appendices; thus table A6 can be found in appendix A 
and is numbered ‘6’. For the most part, figures appearing on tables are rounded. 
References 
Johnson, Z.; Johnson, H. and V. Lambe (1987). Epidemiological Information System Street 
Index, Dublin City and County. 1st Edition. Dublin. Eastern Health Board. 
O’Hare, A. and M. O’Brien (1992). Treated Drug Misuse in the Greater Dublin Area 1990. 
Dublin. The Health Research Board. 
O’ Higgins, K. and P. Duff (1997). Treated Drug Misuse in Ireland. First National Report 1995. 
Dublin. The Health Research Board. 
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Chapter 2 
National Overview - 
Total Treatment Contacts 
Treated Drug Misuse - Numbers Involved and 
the Meaning of these Numbers 
There were 4,865 cases treated for drug misuse in 1996 by treatment services throughout the 
country which reported to the National Drug Treatment Reporting System maintained by the 
Health Research Board. In order to understand the meaning and significance of the figures 
discussed in the report a few words of explanation are presented here. 
It was stressed in Chapter 1 that the National Drug Treatment Reporting System deals with 
treated drug misuse and not with drug use which is not reported to the treatment services. Chapter 
1 also shows that the National Drug Treatment Reporting System provides good, but not 
complete coverage of centres providing treatment for problem drug use in Ireland. Some centres 
do not provide returns due to resource problems, inter alia. In addition, missing from the system 
are those treated for drug misuse in the prisons and by GPs in the community. In addition it 
should be borne in mind that numbers treated depend to an extent on the provision of services. 
These factors would lead to underestimation of treated drug misuse. Conversely, figures based on 
the total treatment group involve some double counting since in Ireland, in contrast to a number 
of other countries, a system of unique identifiers for each client is not in operation. Double 
counting can occur amongst the total treatment group since a client can be attending more than 
one centre at any time and be returned as a contact for all such centres. Precautions are taken to 
avoid duplicate reporting of clients within treatment centres and it can confidently be stated that 
there is little or no duplication of individuals to the National Drug Treatment Reporting System 
from this source. An element of double counting can occur between centres in the Reporting 
System. This is less likely to apply to clients receiving methadone treatment since the 
introduction of the Central Treatment List at the Drug Treatment Centre in 1994. Since that date 
clinicians in treatment centres are expected to return information on clients for whom methadone 
is being prescribed. Thus it is unlikely that clients will receive methadone treatment at more than 
one centre. 
The inclusion of a question on the data collection form relating to ‘currently in treatment at other 
centre’ (Q.7a, see Appendix D) helps to estimate the extent of double counting. 
Table 2.1 shows that 57% of the total treatment group [n=2728] have been treated previously [i.e. 
‘at any time, any place’ or ‘ever treated’]. Of particular relevance to the present discussion is the 
13% [n=614] figure, which is the percentage currently in 
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Table 2.1.  National Data 1996 Total Treatment Group. 
Previously Treated, Currently in Treatment Elsewhere, Name of other Centre Coded. 
Numbers & Percentages. 
Number of Clients in Total Treatment Croup Number %
 4865 100%
Ever Previously Treated Anywhere/Anytime Number Valid %
Never Treated i.e. First Treatment 2041 43%
Previously Treated 2728 57%
Not Known 96 –
Currently In Treatment at Other Centre Number Valid %
Yes 614 13%
No 4083 87%
Not Known 168 –
Name of Other Centre Coded Number Valid %
Not Applicable 4083 89%
Centre in NDTRS 359 8%
Centre not in NDTRS 137 3%
Not Known 286 –
treatment in another centre. Current being defined as ‘in the 30 days prior to the contact date’. 
Eight percent [n=359] are attending other centres which report to the National Drug Treatment 
Reporting System. Thus these are double counted. Three percent [n=137] are being treated in 
centres not in the National Drug Treatment Reporting System so these do not impact on the 
double counting issue. It should be noted however that of those 614 cases currently in treatment 
at another centre and the 168 ‘not known’ cases, information is missing on where 286 of these 
were treated i.e. on whether these were treated in centres included or outside the Reporting 
System. Thus the percentage of double counted contacts could be larger. We could expect the 
extent of double counting to be further augmented if the definition of ‘currently in treatment’ 
extended beyond the 30 previous days. 
Appendix H outlines a method which provides a crude estimation of the number of persons in the 
Reporting System. The method incorporates some of the above considerations. The calculation 
results in an estimated number of 4613 individuals [versus contacts] for the 1996 dataset. This is 
only slightly less that the number of cases in the total treatment group [all contacts] referred to 
throughout this report, which is 4865. We can conclude that the figure for the number of 
individuals treated is likely to approximate closely the ‘all contacts’ figures used throughout this 
report. 
The issue of double counting does not arise of course, in relation to the First Treatment Group - 
these are defined as contacts who have never been treated previously - anytime/anywhere and as 
such when rated, are a measure of incidence. Forty three percent [n=2,041] of the 1996 clients 
were treated for the first time [see Table 2.1]. 
Bearing the discussion above in mind, we look now at the National data on treated drug misuse 
using the following headings - 
a] Socio-Demographic Characteristics 
b] Living Arrangements 
c] Aspects of Drug Misuse 
d] Risk Behaviour 
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a] Socio-Demographic Characteristics 
Nationality and Area of Residence: Almost all [99%] of the total treatment group using the drug 
treatment services in Ireland are of Irish nationality [see Table A 13]. These are not distributed 
equally throughout the country however, 86% of all misusers came from the Eastern Health 
Board area. Even more remarkably, 24% of all clients came from Dublin’s inner city [see Table 
A12]. We shall return to the geographic spread of drug misuse in Chapter 3. 
Gender and Age: Seventy two percent of all contacts were made by males - only 28% by females 
[Table A7]. The majority [65%] were under 25 years of age [Table A8]. Mean age for males was 
24 years and for females, 23 years. 
Education: As found in previous years, the educational attainment of drug misusers is low. Of the 
total treatment group, 58% had left school at or before the age of 15 years; 15 years being the 
statutory minimum age for leaving school in Ireland since 1972. Only 5% of cases were still at 
school [see Table A16].Thus treated drug users have little formal education. 
Employment: In addition to low educational participation and presumably not unrelated, is the 
finding that 83% of all cases were unemployed. Table Bl shows that percentages were similar for 
males and females. The high rate of unemployment amongst drug misusers combined with the 
findings regarding low levels of educational participation suggest reduced access to societal 
resources amongst this group. 
b] Living Arrangements 
Living Situation: Table B2 shows that ‘living with the parental family’ was the most common 
living arrangement for both males [73%] and females [61%] in the total treatment group. In all, 
16% of cases lived with a partner and this living arrangement was more common amongst 
females than males i.e. a slightly larger proportion of females [20%] than males [15%] lived with 
a partner. 
Eight percent of female cases [n=106] were lone parents, while less than 1% [n=27] of male cases 
could be so described. Only 4% of the total treatment group lived alone. These findings indicate 
that problem drug misuse is likely to have an effect upon those with whom drug misusers share 
their accommodation in particular and their lives more generally. 
Living with a drug misuser: Table B3 indicates that as many as 21% of the total treatment group 
were living with a drug misuser. Females rather than males were more likely to live with a 
misuser [28% were females and 18% males]. Shared living arrangements were more likely to be 
with the parental family [48%] or with a partner [39%]; see Table B4. 
c] Aspects of Problem Drug Misuse 
We shall continue to examine the findings related to the total treatment group which we have 
noted numbered 4865 contacts for 1996. This section details the manner in which the drug 
misuser made contact with the services and different aspects of their drug taking behaviour. 
Source of Referral: Figure 2.1 below shows that most referrals to the treatment centres occur on 
the basis of the drug misuser’s own initiative or that of their families [53%] and not on the basis 
of interventions by authorities or outside agencies. Twelve percent of referrals to treatment were 
made by courts, the probation service or by the Gardai. A further 12% were instigated by other 
drug treatment centres and 10% by general practitioners. This suggests that the planned expansion 
of the National Drug Treatment 
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 Self/ 
Family 
Other  Drug 
Treatment 
Centre
General 
Practitioner
Hospital 
/Medical 
Agency
Social 
Services 
Court 
/Probation 
/Police 
Other
Numbers 
Percent 
2500 
53 
539
12
466
10
225
5
144 
3 
551 
12 
268
6
Missing, n=172 
 
Reporting System to include GPs inter alia would increase the validity of the system and increase 
its utility as an aid to service planning and policy framing. Primary Drug of Misuse - Type: 
Figure 2.2 [Table A17] shows that 79% of cases treated for drug misuse involve some type of 
opiate as the primary drug of misuse. This is followed by cannabis, accounting for 12% of cases. 
All others, which include stimulants [6%], hypnotics/sedatives [2%], hallucinogens [0.4%] and 
volatile inhalants [0.5%], together account for only 9% of cases. Thus the national reported drug 
misuse problem is largely associated with opiate misuse. This is similar to other member states of 
the European Union where, although the prevalence of heroin use is usually among the lowest of 
drugs surveyed [1% or less of the general population] ‘heroin is often the main problem drug, 
seen as driving drug related crime or implicated in health indicators such as treatment admissions, 
physical complications, and drug related deaths’ (EMCDDA 1996). 
Primary Drug of Misuse and Age: Figure 2.3 shows the most common primary drug of misuse for 
different age groups. There is a marked difference between the drugs misused by those under 15 
years and all older treated misusers. For those under 15 years, cannabis is the primary drug of 
misuse [58%] followed by volatile inhalants [20%] which is closely followed by opiates [17%]. 
Thus the youngest users in treatment are not using the more problematic drugs. After the age of 
15 however, the primary drug of misuse for all groups are the more problematic opiates with 
relatively fewer reporting stimulants and cannabis as their primary drug of misuse. This points to 
a role for drug prevention initiatives aimed at people as early as primary school level. 
Primary Drug of Misuse and Gender: Bearing in mind that three times as many males present to 
the treatment services, table B5 shows that gender differences are small as far 
 ____________________________ ___________________________ 9 
 
5 
 
 Percentages Numbers  Percentages Numbers 
Opiates 79.0 3839 Volatile Inhalants 0.5 25 
Stimulants 6.0 305 Cannabis 12.0 584 
Hypnotics/Sedatives 2.0 81 Others 0.1 3 
Hallucinogens 0.4 21    
 N=4858; Missing, n=7  
 
 
 
 <15 15-19 20-24 25-29 30-34 35+ Total 
Opiates 17.0 (7) 70.0 (1009) 81.0 (1341) 86.0 (681) 90.0 (499) 82.0 (290) 79.0 (3827) 
Stimulants 2.0 (1) 8.0 (110) 8.0 (139) 5.0 (37) 2.0 (10) 2.0 (6) 6.0 (303) 
Hypnotics/               
Sedatives 2.0 (1) 0.3 (5) 0.4 (7) 1.0 (11) 3.0 (16) 11.0 (40) 2.0 (80) 
Hallucinogens 0.0  0.8 (11) 0.3 (5) 0.5 (4) 0.0  0.3 (1) 0.4 (21) 
Other 0.0  0.1 (1) 0.1 (1) 0.0  0.0  0.3 (1) 0.1 (3) 
Volatile               
Inhalants 20.0 (8) 1.0 (14) 0.1 (1) 0.3 (2) 0.0  0.0  0.5 (25) 
Cannabis 58.0 (24) 20.0 (295) 10.0 (160) 7.0 (59) 5.0 (28) 5.0 (17) 12.0 (583) 
Total 1.0 (41) 30.0 (1445) 34.0 (1654) 16.0 (794) 12.0 (553) 7.0 (355) 100.0 (4842) 
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as type of drug misused is concerned. Proportionately more females were in treatment for opiates 
misuse than males [85% versus 77%], while a higher proportion of males used cannabis as the 
primary drug than females [14% versus 6%]. 
Age First Used Any Drug: Figure 2.4 shows that when asked the age at which they first used any 
drug, 42% indicated that they were under 15 years, while 49% said they were between 15 and 19 
years of age. Thus 91% of the total treatment group had commenced drug use while in their teens. 
This suggests that the key groups to target for health promotion and prevention activities are 
those in their teens and younger children. 
 
 < 15 years 15-19
years
20-24
years
25-29 
years 
30
years +
Number 
Percent  
1787 
42 
2107
49
277
6
65 
2 
38
1
Missing, n=591 
Frequency of Use of Primary Drug: Figure 2.5 shows that the majority - 68% of cases were using 
their primary drug on a daily basis. Fourteen percent used 2 to 6 days a week, and 6% used once a 
week. Table B6 shows that those under 15 years of age rarely used on a daily basis i.e. only 10% 
[n=4] of cases so used. Eleven percent of all cases [n=518] had not used in the past month prior to 
contact with the centre [Table A 19]. 
Duration of Regular Use of Primary Drug: Figure 2.6 shows that there was considerable variation 
amongst the total treatment group in the length of time for which they were taking their stated 
primary drug. Twenty four percent were using for one year or less and 36% for 2 to 3 years. 
Overall, smaller percentages were using for longer durations - 11% for 6 to 9 years and 13% for 
10 years or more. There were little differences by gender here -mean duration of use for males 
was 5 years, for females - 4 years. 
Table 2.2 shows the duration of use for different types of drug. Those misusing a hyponotic or 
sedative tended to have longer histories of use which might perhaps be explained by a small 
number of older benzodiazepine users. For all other categories of drugs the most frequent or 
common duration of use was one to two years. 
Secondary Drug: Clients were asked to identify any other drugs, apart from their primary drug, 
which they were using. Such drugs were recorded as secondary drugs and up to two could be 
recorded. Alcohol could be included here. 
Less than a quarter [24%, n=1102] indicated that they were not using a secondary drug leaving 
3,565 contacts who were [see Table A22]. Thus the majority of drug misusers in 
 ____________________________ ___________________________ 11 
 
 
Frequency 
of Use  
Once per 
Week or less 
2-6 Days per 
Week 
Daily No Use in 
Past Month 
Numbers 
Percent 
292 
6 
664 
14 
3134 
68 
518 
11 
Missing, n=257 
 
 
 
Duration of Regular 
Use of Primary Drug  
1 years & 
less 
2-3 
years 
4-5 
years 
6-9 
years 
10 years 
+ 
Number Percent 1070 
24 
1627 
36 
715 
16 
484 
11 
571 
13 
Missing, n=398 
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Table 2.2. Duration of Use of Primary Drug. Mean, Median, Mode. 
Number of Years. All Contacts. 
 Mean Median Mode Number Missing
Value
Heroin 4 3 2 3549 290
Stimulants 2 2 1 277 28
Hypnotic/Sedative 10 10 6 62 19
Hallucinogens 4 3 2 20 1
Volatile Inhalants 2 1 1 21 4
Cannabis 4 3 2 534 50
Other 7 1 0 3 0
treatment were using a second drug and 434 of them injected this secondary drug. Further 
analysis of the data to explore poly drug usage, showed that 42% [n=l, 925] were using a third 
drug [Table A24]. The number of these cases injecting was 93 [Table A25]. Table A22 shows 
that the most frequently used secondary drugs were cannabis, and benzodiazepines [17% and 
16% respectively] followed by physeptone [11%]. Again cannabis and benzodiazepines proved to 
be the most frequently used third drug [both 10% of total] Table A24. 
d] Route of Administration and Risk Behaviour - Injecting and Needle Sharing Practices 
As previously stated a high percentage [79%] used opiates as the primary drug of misuse. 
Consequently it is important to examine the route of administration of the drug, particularly 
injecting and sharing practices. Sharing injecting equipment is one of the main causes of HIV and 
Hepatitis C infection. Statistics from the Department of Health show that intravenous drug users 
make up the highest proportion of confirmed cases of AIDS in Ireland [42% in 1996]. A study to 
quantify the sero-prevalence of antibody to Hepatitis C virus was carried out among 272 injecting 
drug users at the National Drug Treatment Centre, Trinity Court, over a one year period [Smyth et 
al., 1995]. The overall sero-prevalence was found to be 84% and a significantly greater 
proportion of females tested positive than males. 
Route of Administration of Primary Drug: The manner in which drug misusers take their drugs 
has important implications for public health. Table B7 shows that 44% of cases smoked their 
primary drug while 43% of cases injected. Twelve percent ate or drank the substance and 1% 
sniffed their primary drug. Looking at this data by type of drug, route of administration is on the 
whole, as expected for the different drug types [Table B7]. 
Table B8 shows little difference in route of administration for males and females while Table B9 
shows that the majority of cases over 25 years of age injected their primary drug while 
comparatively younger drug users tended to smoke rather than inject. In 1995, 54% of those aged 
15 to 19 years smoked their primary drug of misuse, compared to 28% [n=369] who injected. In 
1996, there was a further increase in smoking as the primary route of administration - 65% of 15 
to 19 year olds. Thus, there appears to be a shift towards smoking as the most preferred route of 
administration amongst this younger age group. These findings are encouraging indicating a shift 
amongst drug users towards reducing the risks associated with intravenous drug use. It would be 
interesting to explore the other factors related to this changing pattern of behaviour particularly 
the role of health education initiatives. 
Currently Injecting: Table B10 shows that almost one third of users are currently injecting and 
that gender differences are very slight. Table B11 supports the finding above that younger drug 
misusers were less likely to inject than older users. 
 ____________________________ ___________________________ 13 
Ever Injected: Table A29 shows that just over half [n=2551, 55%] injected at some stage in their 
drug taking career. The mean age at which intravenous drug users started to inject was 19 years, 
the most common age of beginning to inject was 18 years. 
Currently Sharing Injecting Equipment: It is difficult to be assured of the validity of this measure 
since peoples’ definition of sharing differs. For example, a person sharing equipment with a 
partner may not consider such behaviour as ‘sharing’. However clients reports were routed 
through the staff of the treatment centres who completed the forms. This provides added 
assurance regarding the validity of the data. 
Taking the group who were currently injecting [n=1492], we find that 26% of these [n=386] 
shared equipment in the course of the previous month. Table B12 shows that women were more 
likely to share equipment than men. 
Summary 
− A majority (86%) of all treated drug misusers were resident in the Eastern Health 
Board area, while nearly a quarter came from the inner city of Dublin 
− Seventy two percent of clients were male 
− Almost two-thirds were under 25 years of age 
− 58% had left school on or before the official school leaving age of 15 years 
− The percentage unemployed was very high at 83%. 
− A high proportion (69%) lived with their parental family, men more so than women. 
On the other hand women were more likely than men to be living with a drug 
misusing partner 
− Most clients (53%) presented to treatment centres on their own initiative or that of 
their family rather than referral from other sources 
− The reported drug misuse problem is largely associated with opiate misuse 
− Cannabis is the main drug of misuse for very young clients 
− The vast majority (91%) started using drugs in their teens 
− Nearly a quarter were misusing their primary drug for over 5 years 
− Comparatively, younger drug users tended to smoke rather than inject 
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Footnotes 
1 Figures discussed in text are rounded for ease of presentation. 
2 Only 6 of the 2,036 cases injecting, inject drugs other than opiates. 
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Chapter 3 
Geographical Overview Based 
on Health Board Areas 
Introduction 
It was noted in Chapter 1 that in 1995 the Drug Treatment Reporting System run by the Drugs 
Research Division of the Health Research Board was expanded to cover the entire country and 
from that date the system is referred to as the National Drug Treatment Reporting System. Thus, 
completed forms for all cases contacting the services within the calendar year are returned to the 
Health Research Board by treatment centres in each Health Board area. The treatment centres 
returning information to the National Drug Treatment Reporting System are listed in Appendix D. 
It is known that patterns of drug misuse and drug subcultures vary from place to place in most 
other countries, the present chapter will elucidate the regional variation in the Irish context. 
There are eight Health Boards in the country which provide health services within defined 
geographical areas [see Map I]. The discussion below relates to the Health Board Area where the 
drug treatment service was delivered. No reports of treatment for problem drug misuse were 
made to the Reporting System by the North Eastern Health Board. In viewing the analyses of the 
data by Health Board Area this needs to be borne in mind. The ‘all contacts’ data set is the main 
focus of analysis in this chapter. Thus the cautions outlined in Chapter 1 apply and in addition we 
must bear in mind here that the numbers involved in the case of some Health Boards are very 
small. 
Health Board Areas - All Contacts and First Contact Data 
Figure 3.1 below shows that there is a great disparity between health boards in the numbers of 
drug misusers treated. The Eastern Health Board treats many more cases than the other health 
boards. As noted above there are no reported cases treated in the North Eastern Health Board 
while the Western and North Western Health Boards treated only 0.2% and 0.3% of the total 
cases respectively i.e. 11 and 13 cases respectively. 
The table shows that 43% of those treated, were contacting the services for the first time. 
Percentages of first contacts within health board areas were far higher for the following - Midland 
Health Board 79%, Mid Western Health Board 72%, South Eastern Health Board 70% and 
Southern Health Board 66%. It can be hypothesised that these findings are due, to some extent, to 
the start up of services in these areas or to the relative newness of the drug misuse problem in 
these health board areas. 
Figure 3.2 below focuses on the Eastern Health Board Area showing numbers and rated data 
relating to First Contacts for the 10 Community Care Areas of the Board. Rates have been 
compiled for the 15-39 age group [based on 1991 Census data] as the majority of drug misusers 
in the treatment reporting system were in that age range. 
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* Irish Census of Population 1991. 
** National Drug Treatment Reporting System. 
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 EHB SHB NWHB MHB WHB MWHB SEHB NEHB TOTAL
All Contacts N 4283 281 13 63 11 83 131 0 4865
Valid % Column 88 6 0.3 1 0.2 2 3 0 100
First Contacts N 1648 185 6 49 4 59 90 0 2041
Valid % Row 39 66 55 79 40 72 70 0 43
 
 
Area of Residence Number Rate per 
1,000
Area of Residence Number Rate per 
1,000
Community Care Area 1 67 1.3 Community Care Area 7 280 5.9
Community Care Area 2 86 1.5 Community Care Area 8 180 2.3
Community Care Area 3 127 3.3 Community Care Area 9 24 0.5
Community Care Area 4 207 3.6 Community Care Area 10 21 0.6
Community Care Area 5 244 5.6  
Community Care Area 6 195 3.5 Total 131 100
* Rotes are per 1,000 population, aged between 15 and 39 years, based on the 1991 Census of Population.
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Community Care Area 7 has the highest rate of first contacts for treated drug misuse at 5.9 per 
1,000 population. This treatment catchment area includes the following high incidence areas - 
Ballybough, North Dock, Mount joy and Ballymun. 
Community Care Area 5 also has a high rate of 5.6 per 1,000 population. This treatment 
catchment area includes the following high incidence electoral areas - Cherry Orchard, 
Clondalkin and Palmerstown. 
Community Care Area 1, an area that covers many of the more affluent southside suburban areas 
of Dublin, has a comparatively low rate of 1.3 per 1,000. The District Electoral Divisions - DEDs, 
in this catchment area are Ballybrack, Blackrock, Cabinteely, Dalkey, Killiney , Foxrock, Dun 
Laoghaire, Shankill and Stillorgan. 
This analysis reinforces previous findings from the Drug Treatment Reporting System and other 
studies indicating higher concentrations of drug misuse - particularly opiate use, amongst areas of 
socio-economic disadvantage. 
Health Board Area Providing Treatment Compared to Area of Residence of Contact 
When we look at the area of residence of cases and examine these in the context of where these 
cases were treated, we see in Table 3.1 below that in 1996 the majority of cases resident in a 
particular Health Board area, were treated in that Health Board area. The notable exception is the 
North Eastern Health Board which we already noted, reported no cases being treated in their area. 
Ninety eight percent [98%, n=48] of cases resident here were treated in the Eastern Health Board 
and one case was treated in the Midland Health Board. Thus it would appear that close 
geographical proximity to established services may have impacted on service use. 
This table shows that the Eastern Health Board provided services to contacts coming from every 
health board area. The Eastern Health Board provided treatment to 110 cases not residing in their 
catchment area; Table 3.1 shows that 48 of these contacts come from the North Eastern Health 
Board, 29 from South Eastern Health Board. Apart from the Eastern Health Board, only the Mid 
Western Health Board [n=46] and South Eastern Health Board [n= 13] provided treatment to 
clients resident in other areas to any notable extent. 
Just under half of the cases treated by the Mid Western Health Board are resident there, 28 come 
from the Eastern Health Board area and 13 from the Southern Health Board. The South Eastern 
Health Board provided treatment to 8 cases who were resident in the Eastern Health Board. These 
figures [though small] are important in the context of service provision and planning. 
Health Board Area - Socio-Demograprics and Problem Drug Misuse 
Health Board Area and Source of Referral: Table Cl provides information on Health Board Area 
and Source of Referral. The table shows that the most frequent source of referral within each 
Health Board differs from area to area. The most frequent source within the North Western 
Health Board was a hospital or other medical agency. General practitioners were the major 
sources of referral for the Western and Mid Western Health Boards. In all other Health Boards 
referrals tended to be initiated more frequently by the client, family or friend. 
Health Board Area - Gender and Age: Chapter 2 revealed that overall 72% of contacts to the 
National Drug Treatment Reporting System were male. Table C2 shows that when the data is 
analysed by Health Board Area, the ratio of males to females is even greater in a number of the 
health boards - particularly those serving a more rural population. For example, in the Midland, 
Mid-Western, North Western and South Eastern Health 
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Table 3.1. Health Board Area of Treatment/Area of Residence. All Contacts. 
Numbers and Percentages. 
Health Board 
Treated 
Area of 
Residence 
 EHB SHB NWHB MHB WHB MWHB NEHB SEHB OUTSIDE
IRELAND
EHB N 
% 
4167 99 15 
5 
4
25
8
11
2
11
4
9
48
98
29 
19 
0
0
SHB N 
% 
0 
0 
276 
90 
0
0
0
0
0
0
2
4
0
0
1 
1 
2
100
NWHB N 
% 
0 
0 
0 
0 
12
75
0
0
1
6
0
0
0
0
0 
0 
0
0
MHB N 
% 
0 
0 
0 
0 
0
0
62
89
0
0
0
0
1
2
0 
0 
0
0
WHB N 
% 
0 
0 
0 
0 
0
0
0
0
11
61
0
0
0
0
0 
0 
0
0
MWHB N 
% 
28 
1 
13 
4 
0
0
0
0
3
17
37
82
0
0
2 
1 
0
0
SEHB N 
% 
8 
.2 
2 
1 
0
0
0
0
1
6
2
4
0
0
118 
79 
0
0
TOTAL 
TOTAL 
N 
% 
4203 
100 
306 100 16
100
70
100
18
100
45
100
49
100
150 
100 
2
100
Area of Residence “Outside Ireland” n=2 in SHB. “ No Fixed Abode” n=6 in EHB 
 
Board areas, more than four out of five reported cases were male. Table C3 shows broadly similar 
age profiles for treated drug misusers in the different health boards. 
Health Board Area and Education: We see from Table C4 that in each Health Board the majority 
of drug misusers had attended [but not necessarily completed] secondary school. More drug 
misusers from the Mid Western Health Board had only reached primary education than in any 
other Health Board. Twenty two percent [n=49] of those in the Southern Health Board were still 
in school. 
Health Board Area and Still at School: Nationally there are 223 school goers amongst the total 
treated drug misuse group. When this data was crosstabulated with drug type, two of these school 
goers could not be assigned to a health board area. Table C5 shows that the majority of school 
goers are treated in the Eastern Health Board [67%; n=149]. Of the 149 Eastern Health Board 
school-going contacts 58% [n=87] are using cannabis and 26% [n=39] opiates while 7% [n=10] 
are using ecstasy. The actual numbers of school going users in the other health boards were as 
follows - 49 in Southern Health Board [35 using cannabis, 9 using ecstasy, 4 volatile inhalants]; 
12 in South Eastern Health Board [11 using cannabis, 1 volatile inhalants], 8 in Midland Health 
Board [3 using cannabis, 3 volatile inhalants and 2 ecstasy] and 3 in the North Western Health 
Board [I using ecstasy, 1 using hallucinogens and 1 cannabis]. 
Health Board Area and Employment: Table C6 shows that there was some differences in 
employment status of clients from the different health boards. While the majority of cases 
receiving treatment for problem drug misuse were unemployed [83%], comparisons between 
health boards show some differences. Those health boards with higher percentages of drug 
misusers in employment were - the Southern Health Board [21%, n=58], South Eastern Health 
Board [22% n=28] and the North Western Health Board [23%, n=3]. Only 9% of cases within the 
 ____________________________ ___________________________ 20 
Eastern Health Board treatment services were in regular employment suggesting different 
patterns and perhaps severity of drug problems in the different areas. 
Health Board Area and Living Arrangements: We know from analysis of national data in Chapter 
2 that 69% of misusers live with the parental family and that 16% live with a partner. When the 
data is looked at by health board [see Table C7], living within the parent home is the most 
frequent arrangement in all Health Boards. The Mid Western Health Board has 18% [n=14] of its 
clients living alone [the equivalent figure for the Eastern Health Board was 3%, n=140] and the 
North Western Health Board has 25% [n=3] in the ‘homeless’/temporary accommodation’ 
category. 
Health Board Area and Living with a Drug Misuser: Table C8 shows that while most contacts 
[79%] did not live with a drug misuser, the percentage of clients living with a drug misuser was 
higher in the Eastern Health Board than in any of the other health board area. 
Health Board Area and Primary Drug of Misuse: Table C9 and Figure 3.3 show that the pattern of 
drug misuse is different in the different health board areas. The Eastern Health Board has 
primarily an opiate problem - 88% of the contacts treated have an opiate problem. There is a 
greater spread of type of drug misused and the numbers involved in such use within the other 
health board areas. Outside the Eastern Health Board the most common drug of abuse within each 
health board is cannabis while the Mid Western Health Board has an equal percentage of opiate 
and cannabis users. 
 
 
Opiates Cannabis Ecstasy  
n Row % n Row % n Row %
Eastern Health Board 3773 88 275 6 125 3
Southern Health Board 14 5 138 49 85 30
Mid Western Health Board 27 32 27 32 18 22
Midland Health Board 7 11 42 67 8 13
South Eastern Health Board 14 11 92 70 16 12
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Figure 3.3 shows that problem use of ecstasy is a feature within services provided by the 
Southern Health Board [30%], Mid Western Health Board [22%] and South Eastern Health Board 
[12%]. Other health boards are not commented on as the numbers involved are quite small. 
Thus the picture emerging regarding pattern of type of drug misused by area would 
appear to be as follows - 
− Eastern Health Board - largely an opiate problem 
− Southern Health Board - cannabis problem followed closely by ecstasy 
− South Eastern Health Board - largely a cannabis problem and ecstasy and opiates to 
a lesser extent 
− Mid-Western Health Board - equal cannabis and opiate problem, ecstasy to a lesser 
extent 
− Midland - largely cannabis 
No general statement will be made regarding the North-Western and Western Health Boards as 
the numbers involved are too small and we have already noted that the North Eastern Health 
Board did not report any contacts to the National Drug Treatment Reporting System. 
Summary 
− There is great disparity between health boards in the numbers treated for problem 
drug misuser. The Eastern Health Board accounted for 88% of treated drug misuse 
while no returns were received from the North Eastern Health Board. 
− Rates of first contacts for treated drug misuse per 1,000 population were calculated 
for Community Care Areas within the Eastern Health Board. These rates varied from 
5.9 per 1,000 population in Area 7 to a rate of 0.5 in Area 9. In general higher 
concentrations of drug misuse are found in areas of socio-economic disadvantage. 
− The majority of cases resident in a particular health board were treated in that health 
board. The data showed that the Eastern Health Board provided services to as many 
as 110 contacts coming from every health board area. Apart from the Eastern Health 
Board only the Mid Western Health Board and South Eastern Health Board provided 
treatment to clients resident in other areas to any notable extent. 
− A number of differences between health boards were found in relation to the socio-
demographic and other background information analysed. 
− The ratio of males to females was somewhat greater in health boards serving a more 
rural population. 
− Sixty seven percent [n=149] of school going drug misusers attending treatment were 
resident in the Eastern Health Board 
− Type of drug misused differed in the different health board areas as follows: 
∗ Eastern Health Board - largely an opiate problem 
∗ Southern Health Board - cannabis problem followed closely by ecstasy 
∗ South Eastern Health Board - largely a cannabis problem; ecstasy and opiate 
misuse to a lesser extent 
∗ Mid-Western Health Board - equal cannabis and opiate problem, ecstasy to a 
lesser extent 
∗ Midland Health Board - largely cannabis problem 
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Chapter 4 
Exploration of Trends in 
Drug Misuse from 1990 to 1996: 
Greater Dublin Area 
Since data on drug misuse at the National level has only been available since 1995, this analysis 
of trends will focus on the Greater Dublin Area where the Reporting System has been in 
operation since 1990. The Greater Dublin Area covers Dublin County Borough [City], its north 
and south suburbs together with Dun Laoghaire County Borough and its suburbs. It is thus not as 
extensive as the Eastern Health Board area, which in addition, includes County Dublin and 
counties Kildare and Wicklow. We noted in the previous chapter that in 1996 as many as 86% of 
drug misusers in the Reporting System were resident in the Eastern Health Board area [n=4203]. 
As expected a smaller percentage i.e. 82% of all contacts are resident1 in the Greater Dublin Area 
[n= 3994]. 
Overview of Numbers of Treated Drug Misusers; 
Greater Dublin Area 1990-1996 
Figure 4.1 shows the numbers treated for drug misuse over the 7 year period in the Greater 
Dublin Area. The graph shows that there has been a steady increase in numbers treated over the 
years [with the exception of a slight drop in the numbers of first contacts in 1991 relative to 
1990]. These increases undoubtedly reflect an increase in overall prevalence of drug misuse over 
the 7 year period. They also, however, reflect the general increased availability of treatment 
services. The rated first contact information shown in the table below shows the general increase 
in annual treated incidence over the period in question. This is supported by much anecdotal 
evidence from people working in the area but also is likely to reflect greater service provision 
over the period in question. 
Trends in Numbers of Treated Drug Misusers. A View by Electoral Area 
Table 4.1 below shows the electoral area of residence of drug misusers, where the frequency of 
all contacts was greater than 50 in any of the 7 years under discussion. Bracketed figures show 
years where frequencies were less than 50. Of course caution is required in interpreting this data, 
since numbers of cases is related to the overall population of the area which is not taken into 
account here. In addition numbers are likely to be effected to some extent by the provision of 
services proximate to the area of residence, the dates when services commenced etc. It needs to 
be acknowledged also that some element of double counting can not be ruled out and for a 
number of years missing data in relation to area of residence is absent from the 
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 1990 1991 1992 1993 1994 1995 1996
All Contact 2037 2359 2555 2919 2978 3593 3994
First Contact 624 450 668 859 1150 1396 1499
First Contact Rated* 1.6 1.2 1.7 2.2 3.0 3.6 3.9
* Rated per 1000 population aged 15-39 years. 
analysis. The latter could result in the underestimation of numbers reported e.g. missing cases 
from 1990 to 1996 are as follows - 112 [1990]; 62 [1991]; 81 [1992]; 168 [1993]; 214 [1994] and 
229 [1996]. These reservations stated, the table below is likely to be of general interest to service 
providers. 
Perusal of Table 4.1 shows a general trend for numbers to increase in the different areas over the 
years. However there are some exceptions and a number of cases occur where 
Table 4.1. Greater Dublin Area. Electoral Areas of Residence of Drug Misusers where 
Frequency of All Contacts >50 Contacts per Annum. 
Frequency  
1990 1991 1992 1993 1994 1995 1996
Artane  (26) 54 (41) 65 115 156 199
Ballyfermot  256 282 330 266 277 374 344
Cabra  81 114 177 228 170 114 110
Clontarf  (44) 51 51 55 75 58 (48)
Crumlin  99 108 116 139 149 159 188
Donaghmede  (43) 83 129 125 128 87 99
Drumcondra  204 240 201 240 226 251 348
Finglas  99 101 209 218 213 173 188
North Inner City  271 275 281 480 412 599 642
Pembroke  (9) (34) (47) (43) (38) 71 78
Rathmines  59 80 62 65 57 77 83
South Inner City  330 419 426 395 386 423 517
Clondalkin  (44) 55 53 58 84 103 141
Greenhills  (14) (25) (26) (23) (7) 97 89
Lucan  (20) (19) (19) (12) (28) 119 164
Tallaght Oldbawn  (13) (18) (23) (24) (12) 89 89
Tallaght Rathcoole  113 119 96 103 136 93 107
Dun Laoghaire  64 58 (49) 58 53 53 64
Mullhuddart  (24) (31) (36) (46) 60 77 89
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numbers increase and fall and visa versa, over the 7 year period. Those involved in the provision 
of services in these areas along with all other interested parties are invited to provide possible 
explanations for the patterns emerging in their areas. Interestingly 11 electoral areas showed less 
that 50 contacts over each of the 7 years. These are Rathfarnham, Terenure, Ballybrack, 
Blackrock, Clonskeagh, Dundrum, Glencullen, Stillorgan, Castleknock, Howth and Swords. 
Future work may relate this data to published social indicator data for these electoral areas. 
Trends 1990 - 1996. Socio-Demographics and Problem Drug Misuse 
The mode, median and mean age of drug misusers over the years can be seen in Table 4.2. For the 
most part it can be said that the age profile of the drug misuser is getting somewhat younger over 
the years, such that the mode age of total treatment contacts for the Greater Dublin Area was 24 
years in 1990 and 20 years in 1996. 
Table 4.2. Greater Dublin Area 1990 - 1996. Mean, Median and Mode Age. 
Total Numbers. All Contacts. 
 1990 1991 1992 1993 1994 1995 1996
Mean 25 25 25 24 24 24 24
Median 25 25 25 23 22 22 22
Mode 24 25 20 20 19 19 20
Numbers 2037 2359 2555 2919 2978 3593 3994
 
As seen from Figure 4.2 below the percentage of teenagers amongst those treated for drug misuse 
has increased over the years 1990 - 1995 with a slight fall in 1996. The numbers however show a 
continuous rise in teenagers treated. 
 
 1990 1991 1992 1993 1994 1995 1996
% Teens 17 16 19 24 30 31 29
n Teens 336 366 473 686 878 1095 1170
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Table 4.3. Greater Dublin Area 1990 - 1996. Treated Drug Misusers Still at School. 
All Contacts. 
 1990 1991 1992 1993 1994 1995 1996
% at School 1990 1991 1992 1993 1994 1995 1996
n at School 3 49 4 75 4 99 4 119 5 138 3 97 4 133
 
Trends in Percentage of Treated Drug Misusers Still at School: Table 4.3 above shows that over 
the 7 year period - 1990 to 1996, little difference in the percentages of treated drug misusers who 
were still at school was observed. The range was 3 to 5 percent of drug misusers. 
Trends in Percentage Unemployed - Treated Drug Misusers: Figure 4.3 shows consistently over 
the years that a very high percentage of treated drug misuse contacts are classified as 
unemployed. In the last three years as many as 90% of those treated in the Greater Dublin Area 
were unemployed. 
Trends in Type of Drug Misuse : Figure 4.4 shows the dramatic rise in the use of heroin over the 
seven year period 1990- 1996 in the Greater Dublin Area and a concurrent fall in the misuse of 
other opiates. It is clear from the graph that treatment for other types of drugs such as cannabis 
and ecstasy is far less a phenomenon in Dublin. It has to be acknowledged, of course, that clients 
misusing these drugs are less likely to present to the treatment services. 
Trends in Injecting and Smoking of Primary Drug: Figure 4.5 shows a clear trend in the total 
treatment data in the Greater Dublin Area - namely that the percentage of people injecting over 
the years 1990 to 1996 has been decreasing while the percentage smoking their primary drug has 
been increasing. This could be explained by an increase in the practice of smoking heroin among 
an increasing young treated population. In 1996, 64% of those presenting for treatment in Dublin 
were less than twenty - five years old, compared to 48% in 1990. This trend is of major 
importance in the public health context 
 
 1990 1991 1992 1993 1994 1995 1996
%Unemployed 89 88 88 89 90 90 90
n Unemployed 1640 1890 2049 2384 2474 3082 3400
Missing 198 220 226 246 216 165 233
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 1990 1991 1992 1993 1994 1995 1996
Heroin 39 37 38 48 56 71 80
Opiates 40 41 38 31 27 16 11
Cannabis 12 13 14 10 10 7 5
Ecstasy 0 2 4 3 3 2
Other 9 9 9 6 5 4 2
 
 
 1990 1991 1992 1993 1994 1995 1996
Inject 68 64 61 62 60 53 49
Smoke 14 17 20 20 26 35 42
Other 18 19 18 18 14 12 9
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given the close association between HIV and other infectious diseases e.g. Hepatitis C with 
intravenous drug use. 
Summary 
− There has been a steady increase in the numbers presenting for treatment for drug 
misuse in the Greater Dublin Area during the seven year period -1990 to 1996 
− The scale of the increase is particularly remarkable in the North Inner City area. 
− Clients presenting for treatment over the seven year period are getting younger. 
− The percentage of teenagers remained relatively constant over the years – between 3 
and 5%. 
− Consistently over the seven year period, levels of unemployment amongst drug 
misusers have remained very high [ranging from 88% to 90%]. 
− The proportion of those treated for heroin use has doubled. 
− Intravenous drug use has become less common while smoking is increasing. 
Footnote 
1 82% resident and treated in Greater Dublin Area. 
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Chapter 5 
Pen Pictures of Selected Drug 
Misuers 
Pen pictures of selected drug misusers are presented below. Key features of the drug and social 
profiles of - heroin, cannabis and ecstasy misusers and school-going drug misusers; are outlined. 
The results are based on the ‘all contacts’ dataset from the National Drug Treatment Reporting 
System for 1996. The general picture emerging does not differ very much when the ‘all contacts’ 
and ‘first treatment’ data sets are compared. This is not surprising since almost three quarters of 
cannabis, ecstasy and school going misusers were treated for the first time in 1996, while 39% of 
heroin users were new to the services. 
Heroin Misusers 
− In 1996 there were 3,373 reported cases treated for heroin misuse in the National 
Drug Treatment Reporting System 
− Most of these heroin misusers had been in contact with the treatment services 
previously. For only 39% [n=l,293], was this their first contact with the drug 
treatment services 
− 54% were referred to treatment by self, friend or family, 14% by another drug 
treatment centre, 10% by court, probation or police 
− 69% of heroin misusers were male 
− The mean age of heroin misusers was 24 years, the most common age - 20 years 
− 1% [n=38] of heroin misusers were still at school 
− Of those heroin users who had left school, the mean and mode age at which they had 
done so was 15 years 
− 98% were resident in the Eastern Health Board area 
− Most [78%] heroin misusers were using this drug on a daily basis; 10% used 2 to 6 
days per week; 4% once a week or less 
− 39% of heroin misusers had been using for 2 to 3 years and 24% for one year or less 
− 63% started using heroin between the ages of 15 and 19 years 
Cannabis Misusers 
− In 1996 there were 584 reported cases treated for cannabis as the primary drug of 
misuse in the National Drug Treatment Reporting System 
− For as many as 73% [n=420] of these, it was their first contact with the drug 
treatment services 
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− 43% of cannabis users were referred to the treatment services by self or family, 27% 
by court, probation or police 
− 86% of treated cannabis misusers were male 
− Mean age of cannabis users was 20 years and mode age was 17 years 
− 25% [n=137] of treated cannabis users were still at school 
− The mean age at which cannabis users left school was 16 years, the mode 15 years 
− 41% of cannabis misusers were resident in the Eastern Health Board; 25% in the 
Southern Health Board and 19% in South Eastern Health Board area 
− 37% of the contacts being treated for cannabis misuse were using on a daily basis; 
29% used 2-6 days a week; 15%o once a week or less 
− 33% had been using for 2 to 3 years and 26% for one year or less 
− 55% started to use cannabis between the ages of 15 and 19 years, 37% started under 
the age of 15 years 
Ecstasy Misusers 
− In 1996 there were 256 reported cases treated for ecstasy misuse in the National 
Drug Treatment Reporting System 
− For 76% [n=192] of these, this was their first contact with the drug treatment 
services 
− 45% were referred to the treatment services by self or family, 19% by the court, 
probation or police, 14% by a general practitioner 
− 77% of treated ecstasy users were male 
− Mean and mode age of ecstasy users was 21 years 
− The mean age at which ecstasy users left school was 16 years the mode 15 years 
− 10% [n=22] were still at school 
− 38% [n=98] were resident in the Eastern Health Board, 39% [n=99] were resident in 
Southern Health Board 
− Generally use was infrequent - only 8% used on a daily basis; 56% used 2 to 6 days 
per week; 14% once a week or less 
− 46% had been using for 2 to 3 years and 37% for one year or less 
− 70% [n=164] started using ecstasy between the ages of 15 and 19 years, 6% [n=14] 
under the age of 15 years 
School Going Drug Misusers 
− In 1996 there were 223 school goers amongst all cases treated for drug misuse in the 
National Drug Treatment Reporting System 
− For 77% [n=167] of these, this was their first contact with the drug misuse services 
− 57% were referred by self or family, 8% by social services, 8% by the court, 
probation police, 8% by general practitioners 
− 65% of school going, treated drug misusers, were male 
− 83% were aged between 15 and 19, 16% less that 15 years, mean and mode age was 
16 years 
− 62% [n=137] of treated school goers were misusing cannabis, 17% [n=38] heroin, 
10% [n=22] ecstasy 
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− 66% [n=146] were resident in the Eastern Health Board [i.e. 31%, n=69 from Dublin 
City North and 27%, n=60 from Dublin City South]; 22% from Southern Health 
Board [n=49] and 5% from South Eastern Health Board [n=12] 
− Generally use was infrequent - 20% used their primary drug daily; 37% - 2 to 6 days 
per week and 24% once a week or less 
− 34% had been using their primary drug for 2 to 3 years and 62% for one year or less 
− 50% started using their primary drug before the age of 15 years; 50% between the 
ages of 15 and 19 years 
Summary 
Comparing the pen pictures above the following main points emerge. 
− Heroin misusers are far more numerous amongst reported cases to the National Drug 
Treatment Reporting System than are the other categories considered above 
− Cannabis and ecstasy misusers are relatively less likely to be referred to the 
treatment services by self or family than are heroin misusers and school going 
misusers 
− Although the majority of misusers in all categories were male, relatively more 
cannabis and ecstasy users were male than were heroin and school going misusers 
− The mean age of treated heroin misusers was 24 years which contrasts with the 
mean age of cannabis and ecstasy users which was 20 and 21 years respectively. 
Mean age of school going drug misusers was 16 years 
− There was little difference in the age at which heroin, cannabis and ecstasy users left 
school - the mode for all three groups was 15 years 
− While only 1% of heroin users were still at school, 25% of cases treated for cannabis 
misuse and 10% for ecstasy misuse were still at school 
− The area of residence of these categories of drug misusers was quite different - 98% 
of treated heroin misusers were resident in the Eastern Health Board area and 66% 
of school goers were so resident. Thirty nine percent of all ecstasy users were 
resident in the Southern Health Board [versus 38% in Eastern Health Board]. After 
the Eastern Health Board [at 41%], xxxxxxx 25% of all cannabis misusers were 
resident in the Southern Health Board and 19% in the South Eastern Health Board 
− Only amongst heroin misusers was daily usage the norm. Only 8% of ecstasy users 
used on a daily basis 
− For all categories, the majority started drug taking in their teens. 
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Appendix A 
National Data. Frequency Tables for All Variables. All 
and First Contacts. Numbers and Valid Percentages. 
 
 All Contacts 
(n = 4865) 
First Contacts 
(n = 2041) 
 n % n % 
Table A1. Type of Contact with Treatment Centre 
New Client  3096 64.0 2041 100.0
Old Client  1744 36.0 n/a —
Total  4840 100.0 2041 100.0
(n/k)  25 — 0 —
Table A2. Ever Previously Treated at Any Centre 
Never treated  2041 42.8 2041 100.0
Previously treated 2728 57.2 n/a —
Total 4769 100.0 2041 100.0
(n/k)  96 — 0 —
Table A3. If Treated - When Last Treated  
Ongoing 1124 28.1 n/a —
2 years & less 738 18.5 n/a —
3-4 years 59 1.5 n/a —
over 4 years 37 0.9 n/a —
never treated  2041 51.0 2041 100.0
Total  3999 100.0 2041 100.0
(n/k)  866 — 0 —
Table A4. In Treatment with Other Centre  
Yes  614 13.1 n/a —
No  4083 86.9 2041 100.0
Total  4697 100.0 2041 100.0
(n/k)  168 — 0 —
Table A5. If in Contact with Other Centre, Name of Other Centre 
In the Reporting System 359 72.4 n/a —
Not In the Reporting System 131 26.4 n/a —
Outside Ireland 6 1.2 n/a 
Total  496 100.0 2041 100.0
(n/a) 4083 — 0 —
(n/k) 286 — 0 —
Table A6. Source of Referral  
Self/Family/Friends 2500 53.3 966 51.2
Other Drug Treatment Centre 539 11.5 112 5.8
General Practitioners 466 9.9 230 11.8
Hospital/Other Medical Agency 225 4.8 96 4.9
Social Services 144 3.1 78 4.0
Court/Probation/Police 551 11.7 293 15.1
Other 268 5.7 140 7.2
Total 4693 100.0 1945 100.0
(n/k) 172 — 96 —
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 All Contacts 
(n = 4865) 
First Contacts 
(n = 2041) 
 n % n %  
Table A7. Gender 
Male  3455 72.0 1465 72.7
Female  1341 28.0 549 27.3
Total  4796 100.0 2014 100.0
(n/k)  69 — 27 —
Table A8. Age 
Less than 15 Years  43 0.9 34 1.7
15 to 19 Years  1446 29.8 898 44.0
20 to 24 Years  1655 34.1 709 34.8
25 to 29 Years  794 16.4 233 11.4
30 to 34 Years  553 11.4 93 4.6
35 to 39 Years  221 4.6 44 2.2
40 Years and Older  136 2.8 28 1.4
Total  4848 100.0 2039 100.0
(n/k)  17 — 2 —
Table A9. Living Status 
Alone  184 4.0 71 3.6
With Parental Family  3227 69.4 1513 76.5
With Friends  102 2.2 43 2.2
With Partner  767 16.5 202 10.2
Institution  51 1.1 22 1.1
Temporary / Homeless  114 2.5 49 2.5
Lone Parent  134 2.9 50 2.5
Other  72 1.5 28 1.4
Total  4651 100.0 1978 100.0
(n/k)  214 — 63 —
Table A10. Living with a Drug Misuser  
Yes  886 21.1 294 16.5
No  3310 78.9 1484 83.5
Total  4196 100.0 1778 100.0
(n/k)  669 — 263 —
Table A11. Resident of City/Area Where Treatment Took Place 
Yes  4509 92.7 1845 90.4
No  355 7.3 196 9.6
Total  4864 100.0 2041 100.0
(n/k)  1 — 0 —
Table A12. Area of Residence 
Dublin North Inner City  642 13.2 214 10.5
Dublin South Inner City  517 10.6 158 7.7
Dublin Remainder North City  1126 23.1 433 21.2
Dublin Remainder South City  1518 31.2 607 29.7
Greater Dublin Area Unspecified  185 3.8 84 4.1
Eastern Health Board Remainder  215 4.4 96 4.7
Total Eastern Health Board  4203 86.3 7592 77.9
Midland Health Board Area  70 1.4 54 2.6
Mid Western Health Board Area  45 0.9 36 1.8
North Eastern Health Board Area  49 1.0 35 1.7
North Western Health Board Area  16 0.3 9 0.4
South Eastern Health Board Area  150 3.1 104 5.2
Southern Health Board Area  306 6.3 198 9.7
Western Health Board Area  18 0.4 9 0.4
Other  8 0.2 4 0.2
Total  4865 100.0 2041 100.0
(n/k)  0 — 0 —
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 All Contacts 
(n = 4865) 
First Contacts 
(n = 2041) 
 n % n % 
Table A13. Nationality   
Irish  4818 99.2 2022 99.2
Other  37 0.8 16 0.8
Total  4855 100.0 2038 100.0
(n/k)  10 — 3 —
Table A14. Employment Status  
Regular Employment 504 10.5 276 13.8
Unemployed 3988 83.4 1520 75.8
Other 288 6.0 208 10.4
Total  4780 100.0 2004 100.0
(n/k)  85 — 37 —
Table A15. Educational Level Reached  
Primary Level 384 8.7 104 5.6 
Secondary Level 3692 83.6 1535 82.0
Third Level 106 2.4 65 3.5
Never went to School  9 0.2 2 0.1
Still in School  225 5.1 167 8.9
Total  4416 100.0 1873 100.0
(n/k)  449 — 168 —
Table A16. Age Left School  
Never went to School  9 0.2 2 0.1
Less than 15 Years  1201 27.6 409 22.3
15 Years  1293 29.7 514 28.0
16 Years  889 20.4 384 20.9
17 Years  445 10.2 210 11.5
18 Years and Older  290 6.7 147 8.0
Still at School  225 5.2 167 9.1
Total  4352 100.0 1833 100.0
(n/k)  513 — 208 —
Table A17. Primary Drug of Misuse  
Heroin  3373 69.4 1293 63.4
Morphine Sulphate Tablets 214 4.4 11 0.5
Physeptone 152 3.1 24 1.2
Other Opiates 100 2.1 15 0.7
Cocaine  25 0.5 17 0.8
Ecstasy 256 5.3 192 9.4
Other Stimulants 24 0.5 16 0.8
Benzodiazepines 57 1.2 13 0.6
Other Hypnotic/Sedative 24 0.5 9 0.4
LSD 20 0.4 10 0.5
Other Hallucinogen 1 0.0 0 0.0
Solvents 18 0.4 12 0.6
Other Volatile Inhalants  7 0.1 6 0.3
Cannabis  584 12.0 420 20.6
Other Drugs 3 0.0 1 0.0
Total  4858 100.0 2039 100.0
(n/k)  7 — 2 —
Table A18. Route of Administration of  Primary Drug  
Inject Smoke  2036 2096 42.6 43.9 492 1192 24.5 59.4 
Eat / Drink  588 12.3 283 14.1 
Sniff  56 1.2 39 1.9 
Total  4776 100.0 2006 100.0 
(n/k)  89 — 35 —
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 All Contacts 
(n = 4865) 
First Contacts 
(n = 2041) 
 n % n % 
Table A19. Frequency of Use of Primary Drug  
Once per Week 292 6.3 141 7.2 
2 to 6 Days per Week 664 14.4 403 20.5
Daily 3134 68.0 1247 63.4
Not Used in the Past Month 518 11.2 176 8.9
Total  4608 100.0 1967 100.0 
(n/k)  257 — 74 —
Table A20. Age First Used Primary Drug  
Less than 15 Years  505 11.1 256 13.2
15 to 19 Years  2717 59.8 1171 60.5
20 to 24 Years  916 20.2 366 18.9
25 Years and Older  406 8.9 142 7.3
Total  4544 100.0 1935 100.0
(n/k)  321 — 106 —
Table A21. Duration of Regular Use of Primary Drug 
One Year and Less  1070 24.0 709 37.0
2 to 3 Years  1627 36.4 790 41.2
4 to 5 Years  715 16.0 214 11.2
6 to 9 Years  484 10.8 132 6.9
10 Years and More  571 12.8 71 3.7
Total  4467 100.0 1916 100.0
(n/k)  398 — 125 —
Table A22. Secondary Drug (1) of Misuse - Type  
No Secondary Drug (1) 1102 23.6 515 26.4 
Heroin 232 5.0 39 2.0
Morphine Sulphate Tablets 215 4.6 42 2.2
Physeptone 529 11.3 180 9.2
Other Opiates 65 1.4 10 0.5
Cocaine  121 2.6 50 2.6 
Ecstasy 380 8.1 215 11.0
Other Stimulants  78 1.7 59 3.1 
Benzodiazepines 752 16.1 221 11.3
Other Hypnotic/Sedative 44 0.9 12 0.6
LSD  86 1.8 54 2.8 
Other Hallucinogen 12 0.3 9 0.5 
Solvents 8 0.2 7 0.4
Other Volatile Inhalants  3 0.1 2 0.1 
Cannabis  776 16.6 392 20.1 
Alcohol  246 5.3 141 7.2 
Other Drugs 18 0.4 4 0.2
Total 4667 100.0 1952 100.0
(n/k)  198 — 89 —
Table A23. Route of Administration of Secondary Drug (1) 
Inject  434 12.8 64 4.6
Smoke 823 24.3 411 29.7
Eat/Drink  2040 60.2 853 61.8
Sniff  90 2.7 52 3.8
Total  3387 100.0 1380 100.0
(n/a)  1102 — 515 —
(n/k) 376 — 146 —
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 All Contacts 
(n = 4865) 
First Contacts 
(n = 2041) 
 n % n % 
Table A24. Secondary Drug (2) of Misuse -Type 
No Secondary Drug (2) 2644 57.9 1076 56.3 
Heroin 29 0.6 12 0.6
Morphine Sulphate Tablets 52 1.1 11 0.6 
Physeptone 141 3.1 47 2.5
Other Opiates 48 1.1 11 0.5
Cocaine 82 1.8 34 1.8
Ecstasy 183 4.0 92 4.8
Other Stimulants 88 1.9 56 2.9
Benzodiazepines 461 10.1 155 8.1 
Other Hypnotic/Sedative 59 1.3 29 1.5
LSD 98 2.1 52 2.7
Other Hallucinogen 9 0.2 4 0.2
Solvents 3 0.1 1 0.1
Other Volatile Inhalants  1 0.0 1 0.1
Cannabis  471 10.3 209 11.0
Alcohol  177 3.9 114 6.0
Other Drugs 23 0.5 7 0.4 
Total 4569 100.0 1911 100.0
(n/k)  296 — 130 —
Table A25. Route of Administration of Secondary Drug (2) 
Inject Smoke  93 462 5.2 25.7 17 207 2.1 26.3
Eat /Drink  1157 64.4 516 65.5
Sniff  84 4.7 48 6.1
Total  1796 100.0 788 100.0
(n/a) 2644 — 1076 —
(n/k)  425 — 177 —
Table A26. Age First Used Any Drug 
Less than 15 Years  1787 41.8 779 42.3
15 to 19 Years  2107 49.3 907 49.3
20 to 24 Years  277 6.5 113 6.1
25 to 29 Years  65 1.5 26 1.4
30 to 34 Years  25 0.6 13 0.7
35 Years and Older  13 0.3 2 0.1
Total  4274 100.0 1840 100.0
(n/k)  591 — 201 —
Table A27. Currently Injecting 
Yes  1492 32.3 421 21.2
No  3128 67.7 1564 78.8
Total  4620 100.0 1985 100.0
(n/k)  245 — 56 —
Table A28. If Injecting, Shared Past Month 
Yes  386 31.3 118 32.3
No  847 68.7 247 67.7
Total  1233 100.0 365 100.0
(n/a) 3128 — 1564 
(n/k)  504 — 112 —
Table A29. Ever Injected 
Yes  2551 54.5 635 32.3
No  2128 45.5 1330 67.7
Total  4679 100.0 1965 100.0
(n/k)  186 — 76 —
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 All Contacts 
(n = 4865) 
First Contacts 
(n = 2041) 
 n % n % 
Table A30. If Injected, Age First Injected 
Less than 15 Years 115 5.1 17 3.0
15 to 19 Years 1283 56.4 305 54.0
20 to 24 Years 642 28.2 179 31.7
25 to 29 Years 181 8.0 49 8.7
30 to 34 Years 36 1.6 10 1.8
35 Years and Older 16 0.7 5 0.8
Total 2273 100.0 565 100.0
(n/a) 2128 — 1330 —
(n/k) 464 — 146 —
Table A31. If Injected, Ever Shared 
Yes 1532 68.6 282 50.6
No 701 31.4 275 49.4
Total 2233 100.0 557 100.0
(n/a) 2128 — 1330 —
(n/k) 504 — 154 —
n/k = not known 
n/a = not applicable 
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Appendix B 
National Data. Frequency Tables for All Variables. 
All and First Contacts. Numbers and Valid Percentages. 
 
Table B1. Employment Status by Gender 
Employment Status Male Female Total 
Unemployed 82.6 86.0 83.5
Regular Employment 12.0 6.3 10.4
Other 5.4 7.6 6.0
Per cent  100.0 100.0 100.0
N=  3404 1310 4714
n/k=151 
Table B2. Living Status by Gender 
Living Status  Male Female Total 
Alone  4.2 3.5 4.0
With Parental Family With Friends  72.7 2.3 60.6 2.0 69.4 2.2
With Partner  15.0 20.2 16.4
Institution  1.2 0.9 1.1
Temporary / Homeless Lone Parent  2.4 0.8 2.6 8.4 2.4 2.9
Other  1.4 1.9 1.6
Per cent  100.0 100.0 100.0
N=  3321 1263 4584
n/k = 281 
Table B3. Living with a Drug Misuser by Gender 
Living with a Drug Misuser  Male Female Total 
Yes  18.1 28.2 20.9
No  81.9 71.8 79.1
Per cent  100.0 100.0 100.0
N=  2982 1157 4139
n/k = 726 
Table B4. Living Status by Living with a Drug Misuser 
Living Status  Yes No Total
Alone  0.0 5.6 4.4
With Parental Family With Friends  48.5 4.6 74.6 1.5 69.1 2.1
With Partner  38.7 11.1 16.9
Institution  2.4 0.9 1.2
Temporary / Homeless Lone Parent  2.7 1.1 1.4 3.6 1.7 3.1
Other  1.9 1.3 1.5
Per cent  100.0 100.0 100.0
N=  878 3287 4165
n/k = 700 
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Table B5. Primary Drug of Misuse by Gender 
Employment Status Male Female Total 
Opiates 76.8 84.7 79.0
Stimulants 6.9 4.9 6.3
Hypnotics-Sedatives 1.2 3.0 1.7
Hallucinogens 0.4 0.4 0.4
Volatile Inhalants 0.5 0.7 0.5
Cannabis  14.3 6.1 12.0
Other  0.0 0.1 0.1
Per cent  100.0 100.0 100.0
N= 3452 1337 4789
n/k = 76 
Table B6. Frequency of Use of Primary Drug by Age (Years) 
Frequency of Use  <15 15-19 20-24 25-29 30-34 35 + Total 
Once per Week or Less  30.0 8.1 5.5 5.9 4.9 3.6 6.4
2-6 Days per Week  37.5 21.7 13.0 10.1 7.7 8.6 14.4
Daily   10.0 61.8 71.8 70.5 72.9 69.2 68.0
No Use Past Month  22.5 8.3 9.7 13.5 14.5 18.6 11.2
Per cent   100.0 100.0 100.0 100.0 100.0 100.0 100.0
N =   40 1378 1590 742 509 338 4597
n/k = 268 
Table B7. Route of Administration of Primary Drug by Primary Drug 
Route of Administration  Opiates Stim. Hyp./Sed Halluc. Cannabis Other Total 
Inject 53.8 1.0 2.6 4.8 0.0 0.0 42.6
Smoke 40.5 2.0 0.0 0.0 97.7 0.0 43.9
Eat/Drink 5.6 88.0 97.4 95.2 1.9 10.7 12.3
Sniff 0.1 9.0 0.0 0.0 0.3 89.3 1.2
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N =  3774 300 78 21 574 28 4775
n/k = 90 
Table B8. Route of Administration of Primary Drug by Gender 
Route of Administration Male Female Total 
Inject Smoke 42.1 44.5 43.8 42.3 42.6 43.9
Eat / Drink 12.2 13.0 12.4
Sniff 1.3 1.0 1.2
Per cent 100.0 100.0 100.0
N=  3397 1312 4709
n/k =156 
Table B9. Route of Administration of Primary Drug by Age (Years) 
Route of Administration  <15 15-19 20-24 25-29 30-34 35 + Total 
Inject  2.5 22.7 42.2 59.5 65.7 57.3 42.7
Smoke  70.0 65.3 44.8 28.0 21.8 19.9 43.9
Eat / Drink  5.0 10.6 12.3 11.4 11.8 21.9 12.2
Sniff  22.5 1.4 0.7 1.2 0.7 0.9 1.2
Per cent  100.0 100.0 100.0 100.0 100.0 100.0 100.0
N=  40 1420 1626 782 542 351 4761
n/k = 104 
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Table B10. Currently Injecting by Gender 
Currently Injecting Male Female Total 
Yes 32.1 32.9 32.3
No 67.9 67.1 67.7
Per cent 100.0 100.0 100.0
N= 3292 1265 4557
n/k = 308 
Table B11. Currently Injecting by Age (Years) 
Currently Injecting <1S 15-19 20-24 25-29 30-34 35 + Total 
Yes 2.3 18.6 35.4 45.4 44.8 31.5 32.4
No 97.7 81.4 64.6 54.6 55.2 68.5 67.6
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N = 43 1397 1589 742 504 333 4608
n/k =257 
Table B12. Currently Sharing by Gender 
Currently Sharing Male Female Total 
Yes 28.7 37.3 31.0
No 71.3 62.7 69.0
Per cent 100.0 100.0 100.0
N= 886 335 1221
n/k = 12 
n/a = 3632= 
n/k = not known 
n/a = not applicable 
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Appendix C 
Health Board Areas. Crosstabulations of Selected 
Variables. All Contacts. 
Valid Percentages and Total Numbers 
 
Table C1. Health Board Area by Source of Referral 
Health 
Board 
Area 
Self/ 
Family 
Other 
Treatment 
Centre 
C.P. Hospital/ 
Medical 
Agency 
Social 
Services
Court/ 
Probation 
/Police 
Other Total % Total N
EHB 54.7 12.7 8.6 4.1 2.8 11.3 5.8 100.0 4116
MHB 48.4 3.2 11.3 14.5 0.0 21.0 1.6 100.0 62
MWHB 15.7 3.6 45.8 10.8 13.3 7.2 3.6 100.0 83
NWHB 7.7 7.7 15.4 53.8 0.0 15.4 0.0 100.0 13
SEHB 42.2 3.9 9.4 7.0 6.3 28.9 2.3 100.0 128
SHB 52.5 1.8 17.1 6.4 3.2 10.4 8.6 100.0 280
WHB 18.2 0.0 45.5 27.3 9.1 0.0 0.0 100.0 11
Total % 53.3 11.5 9.9 4.8 3.1 11.7 5.7 100.0 4693
n/k = 172 
 
 
Table C2. Health Board Area by Gender 
Health Board Area  Male Female Total % Total N 
EHB  71.0 29.0 100.0 4224
MHB  90.2 9.8 100.0 61
MWHB  85.4 14.6 100.0 82
NWHB  83.3 16.7 100.0 12
SEHB  83.5 16.5 100.0 127
SHB  73.5 26.5 100.0 279
WHB  72.7 27.3 100.0 11
Total %  72.0 28.0 100.0 4796
n/k = 69 
 
 
Table C3. Health Board Area by Age (Years) 
Health Board Area  <15  15-19  20-24  25-29  30-34  35+  Total %  Total N 
EHB 0.8 28.6 34.4 16.8 12.1 7.2 100.0 4267
MHB 0.0 42.9 33.3 7.9 11.1 4.8 100.0 63
MWHB 0.0 31.3 39.8 16.9 4.8 7.2 100.0 83
NWHB 0.0 30.8 30.8 15.4 7.7 15.4 100.0 13
SEHB 0.8 30.8 38.5 20.0 6.2 3.8 100.0 130
SHB 2.1 46.3 26.3 10.0 5.3 10.0 100.0 281
WHB 0.0 0.0 36.4 9.1 18.2 36.4 100.0 11
Total % 0.9 29.8 34.1 16.4 11.4 7.4 100.0 4848
n/k = 17 
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Table C4. Health Board Area by Level of Education Reached 
Health Board 
Area 
Never went 
to School 
Primary Secondary Third Still at 
School 
Total % Total N 
EHB 0.2 8.8 85.8 1.4 3.9 100.0 3919
MHB 0.0 6.6 77.0 3.3 13.1 100.0 61
MWHB 1.4 26.4 59.7 12.5 0.1 100.0 72
NWHB 0.0 0.0 50.0 12.5 37.5 100.0 8
SEHB 0.0 12.3 68.9 9.0 9.8 100.0 122
SHB 0.4 0.0 64.4 12.4 21.8 100.0 225
WHB 0.0 11.1 77.8 11.1 0.0 100.0 9
Total % 0.2 8.7 83.6 2.4 5.0 100.0 4416
n/k = 449 
 
 
 
Table C5. Clients Still At School. Health Board Area by Primary Drug of Misuse 
Health 
Board Area 
Opiates Ecstasy Benzo- 
diazepines
Halluc- 
inogens 
Volatile 
Inhalants 
Cannabis Other 
Drugs 
Total 
% 
Total N 
EHB 26.2 6.7 0.7 0.7 6.0 58.4 1.3 100.0 149
MHB 0.0 25.0 0.0 0.0 37.5 37.5 0.0 100.0 8
NWHB 0.0 33.3 0.0 33.3 0.0 33.3 0.0 100.0 3
SEHB 0.0 0.0 0.0 0.0 8.3 91.7 0.0 100.0 12
SHB 0.0 18.4 0.0 0.0 8.2 71.4 2.0 100.0 49
Total % 17.6 10.0 0.5 0.9 7.7 62.0 1.4 100.0 221
n/k = 2 
n/a = 4642 
 
 
 
Table C6. Health Board Area by Employment Status 
Health Board 
Area 
Unemployed Regular 
Employment
Other Total % Total N 
EHB 86.0 9.4 4.6 100.0 4217
MHB 68.3 12.7 19.0 100.0 63
MHWB 83.8 12.5 3.8 100.0 80
NWHB 46.2 23.1 30.8 100.0 13
SEHB 66.1 22.0 11.8 100.0 127
SHB 57.2 21.4 21.4 100.0 271
WHB 77.8 11.1 11.1 100.0 9
Total % 83.4 10.5 6.0 100.0 4780
n/k = 2 
n/a = 4642 
 
 
 
Table C7. Health Board Area by Living Status 
Health 
Board 
Area 
Alone Parental 
Family 
Friends Partner Institution Temporary/
Homeless 
Lone 
Parent 
Other Total 
% 
Total 
N 
EHB 3.4 70.1 1.9 16.9 0.8 2.6 2.9 1.4 100.0 4084
MHB 4.8 71.4 3.2 17.5 1.6 0.0 1.6 0.0 100.0 63
MHWB 17.5 46.3 8.8 16.3 3.8 2.5 3.8 1.3 100.0 80
NWHB 0.0 50.0 16.7 8.3 0.0 25.0 0.0 0.0 100.0 12
SEHB 7.0 63.3 3.9 13.3 4.7 1.6 2.3 3.9 100.0 128
SHB 6.5 67.8 2.9 12.3 3.3 0.7 3.3 3.3 100.0 276
WHB 0.0 87.5 0.0 12.5 0.0 0.0 0.0 0.0 100.0 8
Total % 4.0 69.4 2.2 16.5 1.1 2.5 2.9 1.5 100.0 4651
n/k = 214 
 
 ____________________________ ___________________________ 45 
 
Table C8. Health Board Area by Living with a Drug Misuser 
Health Board Area  Yes No Total % Total N
EHB  22.4 77.6 100.0 3645
MHB  5.1 94.9 100.0 59
MWHB  17.5 82.5 100.0 80
NWHB  18.2 81.8 100.0 11
SEHB  11.0 89.0 100.0 118
SHB  12.8 87.2 100.0 273
WHB  10.0 90.0 100.0 10
Total %  21.1 78.9 100.0 4196
n/k = 669 
 
 
 
Table C9. Health Board Area by Primary Drug of Misuse 
Health 
Board Area 
Opiates Cocaine Ecstasy Benzo- 
diazepines
Halluc- 
inogens 
Cannabis Other 
Drugs 
Total 
% 
Total 
N 
EHB  88.2 0.5 2.9 1.0 0.3 6.4 0.7 100.0 4276
MHB  11.1 0.0 12.7 0.0 1.6 66.7 7.9 100.0 63
MWHB  32.5 1.2 21.7 1.2 7.2 32.5 3.6 100.0 83
NWHB  7.7 7.7 23.1 7.7 7.7 46.2 0.0 100.0 13
SEHB  10.7 2.3 12.2 0.8 0.0 70.2 3.8 100.0 131
SHB  5.0 0.0 30.2 3.6 0.7 49.1 11.4 100.0 281
WHB  27.3 0.0 9.1 18.2 0.0 36.4 9.1 100.0 11
Total %  79.0 0.5 5.3 1.2 0.4 12.0 1.5 100.0 4858
n/k=7  
Total % = Total Column % 
n/k = not known 
n/a = not applicable 
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Appendix D 
National Drug Treatment Reporting System - 
Treatment Centres Providing Returns in 1996 
Eastern Health Board Area 
Drug Treatment Centre, Trinity Court 
A statutory out-patient service providing detoxification, methadone maintenance, social, 
psychological and psychiatric assessment, urine screening, needle exchange, counselling 
and advisory service. Inpatient detoxification service attached to Beaumont Hospital. 
Coalmine Therapeutic Community 
A voluntary non-prescribing agency providing drug free programmes, day programme - 
family and groups, prevention programme, drug and HIV counselling and support at 
induction, residential and after care level. 
Rutland Centre 
A voluntary non-prescribing agency providing assessment, counselling and therapy at 
residential and day care level. 
Mater Dei Counselling Centre 
A voluntary specialised counselling unit for adolescents, providing services such as 
individual counselling, family therapy and drama group. 
Teen Counselling, Clondalkin 
A voluntary specialised counselling service for adolescents and their parents under the 
auspices of the Mater Dei Counselling Centre. 
Teen Counselling, ‘Shalom’, Tallaght 
A voluntary specialised counselling service for adolescents and their parents under the 
auspices of the Mater Dei Counselling Centre. 
Ballymun Youth Action Project 
A voluntary non-prescribing community based agency offering individual and family 
counselling, information on drug abuse, support for abusers and families, referral, 
community education, outreach and a range of social activities. 
RIalto Community Drug Team 
A partnership between the Eastern Health Board and the local community, providing a 
local drug service for drug users and their families and the general community. Services 
include drop-in, advice, information, counselling, referral, and the provision of personal 
development, assertiveness and social skills programmes to promote re-integration of drug 
users. 
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Talbot Day Centre 
A statutory community-based programme for drug free youth providing individual and 
group counselling, family therapy, prevention education, group recreational activities and 
parent groups. 
Castle Street Health Centre 
A statutory non-prescribing community based agency offering individual counselling, 
group work, family counselling and a range of social activities. 
Tallaght Health Centre 
A statutory non-prescribing community based agency offering individual counselling, 
group work, family counselling and a range of social activities. 
Roselawn Health Centre 
A statutory non-prescribing community based agency offering individual counselling, 
group work, family counselling and a range of social activities. 
Edenmore Health Centre 
A statutory non-prescribing community based agency offering individual counselling, 
group work, family counselling and a range of social activities. 
Baggot Street Clinic 
A statutory community-based Addiction Centre providing information for parents, 
community groups, schools, education and HIV prevention services, primary care, 
addiction counselling, community welfare, methadone dispensing and aftercare 
rehabilitation. 
City Clinic 
A statutory community-based Addiction Centre providing information for parents, 
community groups, schools, education and HIV prevention services, primary care, 
addiction counselling, community welfare, methadone dispensing and aftercare 
rehabilitation. 
Aisling Clinic 
A statutory community-based Addiction Centre providing information for parents, 
community groups, schools, education and HIV prevention services, primary care, 
addiction counselling, community welfare, methadone dispensing and aftercare 
rehabilitation. 
Domville House 
A statutory community-based Addiction Centre providing information for parents, 
community groups, schools, education and HIV prevention services, primary care, 
addiction counselling, community welfare, methadone dispensing and aftercare 
rehabilitation. 
Trinity Court, Third Floor 
A statutory community-based Addiction Centre providing information for parents, 
community groups, schools, education and HIV prevention services, primary care, 
addiction counselling, community welfare, methadone dispensing and aftercare 
rehabilitation. 
Patrick Street, Dun Laoghaire 
A statutory community-based Addiction Centre providing information for parents, 
community groups, schools, education and HIV prevention services, primary care, 
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addiction counselling, community welfare, methadone dispensing and aftercare 
rehabilitation. 
Kildare Addiction Services 
A statutory non-prescribing addiction counselling service. 
Cuon Dara 
A statutory inpatient service offering a specialised detoxification programme, counselling, 
psychotherapy and rehabilitation. 
Clondalkin Addiction Support Programme (CASP) 
A voluntary Satellite Clinic with statutory support, operated by a general practitioner who 
has access to the specialist medical and counselling staff at an Addiction Centre. Services 
include methadone prescription which is dispensed by retail pharmacists, urine screening 
and counselling. 
Young Persons Programme 
A statutory programme for young persons operated by a general practitioner and supported 
by local community.    Services include medical stabilisation and detoxification, 
counselling, group meetings and workshops for clients and parents facilitated by outreach 
workers and peer workers. 
St. Patrick’s Institution 
A detoxification, counselling and support service. 
Southern Health Board area 
Arbour House Treatment Centre 
A statutory service providing drug free programmes for teenagers, adolescents and adults. 
Treatment provided in form of therapy and one to one counselling backed by multi-
disciplined professional team. 
Tabor Lodge Treatment Centre 
A voluntary service providing individual and family counselling, education and employee 
assistance programmes and other specialist models. 
North Western Health Board area 
Substance Abuse Centre, Sligo 
A statutory non-prescribing service providing counselling, prevention and education. 
Mental Health Unit, Dungloe District Hospital 
A statutory psychiatric service at in- or out-patient level. 
Community Nursing Unit, Buncrana 
A statutory non-prescribing service providing counselling, prevention and education. 
Midland Health Board area 
Community Alcohol and Drugs Services 
A statutory non-prescribing service operated by professional addiction counsellors at a 
number of local area centres. 
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Western Health Board area 
St. Theresa’s Unit, Castlebar 
A statutory non-prescribing service providing counselling, prevention and education. 
Mid Western Health Board area 
Our Lady’s Hospital, Ennis 
A statutory outpatient psychiatric service providing counselling and support. 
Tevere Day Hospital 
A statutory outpatient psychiatric service providing counselling and support. 
Willowdale Day Hospital 
A statutory outpatient psychiatric service providing counselling and support. 
Bushy Park, Ennis 
A voluntary service providing one to one counselling, peer education, family programmes, 
after care, relapse groups and a residential family programme. 
Cuon Mhuire, Bruree 
A voluntary specialised residential detoxification centre, aftercare, individual counselling, 
group therapy and various rehabilitation programmes. 
South Eastern Health Board area 
ACCEPT Addiction Treatment Service 
A statutory service providing education, prevention, assessment, advice, information, 
individual counselling, group therapy, and family support. 
Aiseiri, Tipperary 
A voluntary organisation providing a professional twelve-step drug free programme, group 
therapy, individual counselling, peer and relapse groups and family support programme. 
Aiseiri, Wexford 
A voluntary organisation providing a professional twelve-step drug free programme, group 
therapy, individual counselling, peer and relapse groups and family support programme. 
Addiction Service, St. Dympna’s Hospital 
A statutory service providing assessment, detoxification, treatment and aftercare, 
counselling, individual group and family therapy advice, information and education. 
Psychiatric Unit, Regional Hospital, Waterford 
A statutory psychiatric service. 
CATS - Community Alcohol Treatment Service 
A statutory service providing individual/family assessment and counselling, support group, 
education and community awareness programme. 
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Appendix E 
Form for Data Collection and Instructions 
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Section A. Treatment Contact Details 
1 Area (Health Board Area) 
Enter two digit code for Health Board Area. 
2. Treatment Centre 
Each treatment centre will be given its appropriate code. 
3 Client Number 
Each client should have a unique code number. The first two digits will be the treatment 
centre code, the remaining digits relate directly to the client. 
4 Date of Treatment Contact 
This refers to the date when the client was first seen by the treatment centre at the start of 
treatment It does not refer to the date when the from was completed. Remember that the 
client should be counted only once in a given year at any one treatment centre. Only the 
date of the start of the first treatment episode in the given year is to be recorded. 
5 Type of Contact with this Centre 
Circle the relevant code. 
A “new client” is a client who is making contact for a drug problem with this particular 
treatment centre for the first time ever (i.e. has never at any time in the past been to this 
centre.) 
An “old client” is one who has been to this particular treatment centre at some time in the 
past. 
In the general services, if the person is already a patient or client, count only a demand for 
treatment for a drug problem. 
It should in all cases be possible to distinguish between new and old clients. 
However, if not known, code 9. 
6(a) Ever previously Treated, at any Treatment Centre 
Circle the relevant code. 
“Never previously treated” refers to a client who has never received treatment for drug 
misuse at any centre anywhere. He/she is thus making a first ever treatment demand for a 
drug problem. 
6(b) If Previously Treated, When Last 7 
Enter number of months since end of last treatment. 
If never treated, code 888 (not applicable). 
At the beginning of the year if the client has been in continuous care (i.e. still in treatment 
from the previous year), enter 000. 
7(a) Currently in Treatment at Other Centre 
Circle relevant code. 
If yes, write in specific centre. 
“Currently in Treatment” refers to a client who is or has been in testament at another 
treatment centre within the last 30 days prior to start of this treatment episode. 
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“No” refers to a client who is not now nor has been in contact with any centre in the past 
30 days. 
7(b) Source of Referral 
Write in the source of referral and circle code. 
Section B. Socio-Demographic Information 
8 Gender 
Circle appropriate code. 
9(a) Age 
Record client’s age in years at time of contact with centre. 
If not known, code 99. 
9(b) Date of Birth 
Write in order; day/month/year (e.g. 07/12/62). 
Check consistency with age. 
10(a) Living Status 
Circle appropriate code and specify where necessary. 
“Living status” refers to current situation (past 30 days). If situation has changed within 
the last 30 days, enter client’s living status as it was immediately prior to treatment 
contact. 
“Parental family” refers to client’s mother and/or father or to extended family such as 
grandparents, uncles, aunts, etc. 
“Friends” - living with friends. 
“Partner” - refers to sexual partner, i.e. spouse or cohabitee. 
“Institution” includes prison, hospital, etc. 
“Temporary/homeless” includes staying with someone temporarily, living in a 
hotel/guesthouse/hostel, sleeping rough, and so on. Use this code only if client’s living 
status is insecure. Do not use this code if client has just moved to a new but stable address. 
10(b) Living with Drug Misusers 
Circle appropriate code. 
“Drug misusers” refers to regular/heavy users of illicit drugs. 
“Living with” refers to people who share the same household. 
People who are living alone or who are homeless should be coded 2 (not living with drug 
misusers. 
11 (a) Resident of Area 
Circle code. Resident means that they usually live in the area where treatment is given, as 
coded at Question 1. 
11(b) Area of Residence 
Write in code according to those established for each area. For residents of the Eastern 
Health Board Area the Epidemiological Information System Street Index is used. In the 
case of other Health Board Areas the County of residence is specified. 
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12. Nationality 
Circle appropriate code. 
If national of other country, specify the country. 
13. Employment Status 
Circle appropriate code, and specify if “Other” (e.g. ‘at school, ‘housewife’, etc.). 
14(a) Highest Education Level 
For clients who are no longer receiving education, write in the highest educational level 
achieved by the client. 
If Primary level, code 1. 
If Secondary level, code 2. 
If Third level, code 3. 
If the client is still receiving education at any level, code 8. 
If not known, code 9. 
14(b) Age Left School 
Record age in years when the client left full-time education at secondary school level (or 
primary level if no secondary level education). Does not refer to post secondary further 
education (e.g. university or professional/technical training). 
If never went to school, code 01. 
If still at school, code 88. 
If not known, code 99. 
Section C. Problem Drug Use 
15(a) Primary Drug 
Record the name of drug that the client gives as the main drug for which he/she is seeking 
treatment. 
If the client is using drugs at the point when he/she makes contact for treatment, then 
record current primary drug (in the 30 days up to the time of treatment). 
However, if a client is drug free then record the primary drug he/she was last using. 
Alcohol may not be recorded as the primary drug of misuse. Clients whose primary drug 
of misuse is alcohol should be excluded. 
Distinguish clients who were using street methadone or other substitute from those who 
were using legitimately prescribed methadone or other substitutes. 
15(b) Route of Administration of Primary Drug 
Record usual route of administration from the codes provided. 
As with the name of the primary drug, if the client is not using his/her primary drug or is 
drug free at the point of treatment contact, record the usual route of administration of the 
primary drug when he/she was last using it. 
15(c) Frequency Past Month 
Record the frequency of use of the primary drug during the past month from the codes 
provided. 
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The frequency of use refers strictly to the last 30 days before the treatment contact. 
If the client is drug free, or has not used his/her primary drug in the past 30 days code 8 
(not used past month). 
15(d) Age at First Use 
Record age in years when client first used the primary drug. 
If not know, code 99. 
15(e) Duration of Regular Use 
Record the number of years the client has been using the primary drug on a regular and 
frequent basis. If not known, code 99. 
16/17Secondary Drugs 
(a)Name(s) of Secondary Drug(s) 
Write in names of up to two drugs which are also part of the drug misuse problem 
presented by the client. 
This item does not attempt to record all other drugs that have been used by the client in the 
past thirty days, but only those that are seen by the client and/or treatment staff as 
significant in the client’s drug misuse problem. Thus occasional or moderate and 
controlled use of alcohol or cannabis would not be included, but bouts of heavy drinking 
or barbiturate intoxication, or episodes of compulsive cocaine use should be included. 
(b)Route of Administration of Secondary Drug(s) 
Record usual route of administration from the codes provided. If drug free or not used in 
past 30 days, code route when last used. 
18. Age First Used Any Drug 
Write in age of first use of drugs (excluding alcohol) for nonmedical purposes. 
Section D. Risk Behaviour 
19(a) Currently Injecting (past month) 
Circle appropriate code. 
“Currently injecting” refers to whether the person has injected any drug at least once in 
past 30 days. 
“Injecting” includes intravenous, intramuscular or subcutaneous administration. 
Excludes bona fide medical injection (e.g. diabetics, vaccinations etc.). 
19(b) If Injecting, Shared in the Past Month 
Circle code. 
Refers to whether the person has shared injecting equipment on at least one occasion 
during the last 30 days. 
If not currently injecting, code 8. 
20(a) Ever Infected 
Circle the relevant code. 
Includes the injection of any drug for nonmedical purposes. Excludes medical injections 
(diabetes, vaccinations etc.). 
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20(b) If Yes, Age First Injected 
Enter age when first injected 
If never injected, enter 8. 
If not known, enter 9. 
20(c) If Ever Injected, Ever Shared 
Circle appropriate code. 
If never injected, enter 8. 
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Appendix F 
Drug Classification 
 
Heroin and Other Opiate Type 
Drugs 
unspecified opiate-type drug 
heroin (street/nonmedical use) 
heroin, diamorphine (“smack”, 
“junk”, “horse”) 
opium and morphine 
(street/nonmedical use) 
morphine (“Napps”, MST) 
opium 
home-made concoction from 
opium poppies or poppy straw 
(“Poppy tea”, “Kompot” etc.) 
other (specified) form of opium or 
morphine or derivative 
codeine (street/nonmedical use) 
unspecified codeine or codeine 
derivative 
codeine linctus (cough mixture) 
hydrocodeine 
dihydrocodeine (DF118, 
Paracodin) 
other (specified) form of codeine 
or derivative 
synthetic opiates (street/nonmedical use) 
unspecified synthetic opiate 
dextromoramide (Palfium) 
dextropropoxyphene (Distalgesic) 
dipipanone (Diconal, “dike”) 
methadone (Physeptone, “phy”) 
pethidine 
other (specified) synthetic opiate 
op la te agon is t-an tagon is ts 
(street/nonmedical) 
unspecified agonist-antagonist 
buprenorphine (Buprex) 
pentazoncine (Fortral) 
 
 
other (specified) opiate agonist- 
antagonist 
substitute opiates/opioids (used as part of 
drug treatment programme) 
unspecified opiate substitute 
methadone 
codeine/dihydrocodeine etc. 
buprenorphine 
heroin 
other 
other (specified) opiate-type drug 
Cocaine Amphetamine and 
Other Stimulants 
unspecified stimulant 
cocaine 
unspecified cocaine (“coke”) 
cocaine hydrochloride 
freebase cocaine (includes “crack”) 
other (specified) form of cocaine 
(e.g. coca paste) 
amphetamines 
unspecified amphetamine 
(“speed”, “uppers”) 
amphetamine sulphate (“sulph”, 
“whizz”) 
dexamphetamine 
methylamphetamine 
methylamphetamine (smokable - 
“ice”, “crystal meth”) 
other (specified) form of 
amphetamine 
other central nervous system stimulants 
unspecified other stimulants (not 
cocaine/amphetamine) 
methylphenidate (Ritalin, Rubifen) 
phenmetrazine (Preludin) 
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ephedrine, norephedrine, 
pseudoephedrine 
other (specified) stimulants 
MDMA 
MethyleneDioxyMethAmpheta- 
mine - MDMA (ecstasy) 
other (specified) central nervous system 
stimulant 
Hypnotics and Sedatives 
unspecified hypnotic/sedative-type drug 
barbiturates and other hypnotics 
unspecified hypnotic 
barbiturates 
methaqualone (Mandrax) 
glutethimide (Doriden) 
chlormethiazole (Heminevrin) 
other (specified) hypnotic, 
excluding benzodiazepines 
benzodiazepines 
unspecified benzodiazepine 
(“benzos”) 
diazepam (Valium, Anxicalm) 
flurazepam (Dalmane) 
flunitrazepam (Rohypnol) 
lorazepam (Ativan) 
oxazepam (Serenid) 
nitrazepam (Mogadon) 
temazepam (Euphypnos, 
Normison) 
other (specified) benzodiazepine 
major tranquillisers 
unspecified major tranquillisers 
unspecified major tranquillisers 
other (specified) sedative/anxiolytic, 
excluding benzodiazepines 
Hallucinogens 
unspecified hallucinogenic substances 
manufactured drugs 
unspecified manufactured drug 
(“designer drug”) 
lysergic acid (LSD, “acid”) 
phencyclidine (PCP, “angel dust”) 
other (specified) manufactured 
hallucinogen or “designer” drug 
mushrooms and other plants and derivatives 
unspecified mushrooms (“liberty 
caps”, “magic mushrooms”) 
Amanita Muscaria 
psilocybin 
other (specified) hallucinogenic 
plant 
other (specified) hallucinogenic substance 
(mescaline) 
Volatile Inhalants 
unspecified volatile inhalants 
glue 
butane 
solvents 
petrol 
nitrites 
other (specified) volatile inhalants 
Cannabis 
unspecified cannabis (“pot”, “joint”, “dope”, 
“blow”, “draw” ) 
cannabis 
herbal (marijuana, “grass”) 
resin (hashish, “hash”) 
oil 
other (specified) form of cannabis 
Other Drugs 
unspecified other drug/substances 
unspecified medicaments 
speedball (heroin and cocaine 
cocktail) 
antiparkinsonian drugs 
antidepressant drugs (tricyclics) 
other (specified) drug 
Alcohol (as a secondary drug only) 
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Appendix G 
Population of Ireland 1991. 
Health Board Area by Age. Numbers. 
 
Age  EHB SHB NWHB MHB WHB MWHB NEHB SEHB Ireland 
>15  316548 139553 57403 57879 92402 84136 86356 106297 940574 
15-19  120339 49902 19118 19313 32182 29998 28208 35966 335026 
20-24  112370 38765 12951 13231 21908 21516 19720 26111 266572 
25-29  100330 36277 12043 12962 19574 19958 19396 25781 246321 
30-34  94314 36579 13227 13856 22515 21342 20798 26440 249071 
35-39  86265 35497 13201 13482 22471 20991 20600 25382 237889 
40-44  80667 34176 13098 12370 21328 20402 19601 24041 225683 
45+  334392 161514 67133 59891 110594 92385 85504 113170 1024583 
Total  1245225 532263 208174 202984 342974 310728 300183 383188 3525719 
Source: Ireland Census of Population 1991. Dublin: The Stationery Office 
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Appendix H 
Calculation of Number of Individuals Treated in 1996 
and Rates per 1,000 Population 
The calculation below endeavours to ‘correct’ the total number of contacts in the 1996 dataset for 
any ‘double counting’ which may have resulted from contacts reporting that they are Currently in 
treatment at other centre i.e. Question 7 [see Appendix D] on the form returned by treatment 
centres to the National Drug Treatment Reporting System. It thus estimates the number of 
individuals [not contacts] in the National Drug Treatment Reporting System. See O’Hare and 0’ 
Brien [1992]1 for full discussion of the method of estimation. 
The numbers and rates below are estimates of the individuals resident in each Health Board Area 
who presented to the treatment services during 1996 [not necessarily in the Health Board of 
residence] for treatment of a drug problem.   These are based on calculations of responses to 
Question 7 - Currently in treatment at other centre. Rates are based on Census of Population 
1991, ages 15-39. 
 
Age  EHB SHB NWHB MHB WHB MWHB NEHB SEHB Ireland 
Number 3960 301 13 70 17 45 48 146 4613
Rate 7.7 1.5 0.2 1.0 0.1 0.4 0.4 1.0 3.5
 
Example - Calculation of Ireland Figure 
The following elements of the responses are summed - 
A + B + C + D where 
A = those not currently in contact with another centre 
[n = 4083, see Table A4] 
B = those currently in contact with a centre outside the Reporting System 
[n=137, see Table A5] 
C = those currently in contact with a centre in the Reporting System divided by 2 
[n=359/2 = 179, see Table A5] 
D = the ‘not known’ category [n=286, see Table A5] half of whom are assumed to be currently in 
contact with a centre outside the system [286/2 = 143] and the other half assumed to be 
currently in contact with a centre in the system - this number is halved [143/2=711] 
[n= 143 + 71 =214] 
Estimate of Number of Individuals, Ireland 
=A+B+C+D or 4083 + 137 + 179 + 214 = 4613 
All Contacts, Ireland, Data 1996 Report = 4865 
Footnote: 1 O’Hare, A. and M. O’Brien (1992). Treated Drug Misuse in the Greater Dublin Area 1990. 
Dublin. The Health Research Board. 
